CURRICULUM VITAE
William C. Miller
Education
1997 MPH Dept. of Epidemiology, School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC
1989 PhD Dept. of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD
1985 MD The Johns Hopkins University School of Medicine, Baltimore, MD
1981 AB Dept. of Psychology, Princeton University, Princeton, NJ
Post-Graduate Training
1995 - 1997 Robert Wood Johnson Clinical Scholar, University of North Carolina at Chapel Hill, Chapel Hill, NC
1991 -1994 Fellow, Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC
1991 -1992 Fellow in International Health, Department of Medicine, Muhimbili Medical Center, Dar es Salaam, Tanzania and Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC
1989 -1991 Resident in Medicine, Department of Medicine, The University of Maryland and Baltimore Veterans Administration Hospitals, Baltimore, MD
1988 -1989 Intern in Medicine, Department of Medicine, The University of Maryland and Baltimore Veterans Administration Hospitals, Baltimore, MD
1986 -1988 Postdoctoral Fellow, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD
1985 -1986 Postdoctoral Fellow, Interdisciplinary Training Program, Departments of Neuroscience and Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, MD
Professional Positions
2014 - present Professor, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
1 Created on 2/6/2015 8:57:37 AM CURRICULUM VITAE - William C. Miller
2014 - present Professor, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
2010 - present Program Director, Training Program in Sexually Transmitted Diseases and HIV, University of North Carolina at Chapel Hill, Chapel Hill, NC
2005 - present Senior Investigator, UNC Project, Lilongwe, Malawi
2005 - 2014 Associate Professor, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
2005 - 2014 Associate Professor, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
2006 - 2012 Program Director, Program in Health Care Epidemiology and Clinical Research, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
1999 - 2005 Assistant Professor, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
1999 - 2005 Assistant Professor, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
1997 - 1998 Clinical Assistant Professor, Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
1997 - 1998 Clinical Assistant Professor, Department of Epidemiology and Public Health Leadership Program, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
1995 - 1997 Clinical Instructor (non-salaried), Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
1995 - 1997 Medical Advisor (part-time consultant, unpaid), Division of HIV Prevention, Family Health International, Research Triangle Park, NC
1990 -1991 Assistant Instructor (non-salaried), Department of Medicine, The University of Maryland School of Medicine, Baltimore, MD
Professional Societies
Infectious Diseases Society of America
American Sexually Transmitted Diseases Association
Honors and Awards
2012 Fellow, Infectious Diseases Society of America
2009 2009 Distinguished Teaching Award for Post-Baccalaureate Instruction,
2 CURRICULUM VITAE - William C. Miller
The University of North Carolina at Chapel Hill, Chapel Hill, NC
2006 Nominee, Faculty Award for Excellence in Doctoral Mentoring, The Graduate School, University of North Carolina at Chapel Hill, Chapel Hill, NC
2003 Nominee, John E. Larsh, Jr. Mentorship Award, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
2001 Nominee, McGavran Teaching Award, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
1997 Delta Omega, Public Health Honor Society, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
1981 High Honors, Department of Psychology, Princeton University, Princeton, NJ
1981 Phi Beta Kappa, Princeton University, Princeton, NJ
1977 Valedictorian, Susquehanna Valley High School, Conklin, NY
Medical Licensure
1994 North Carolina
1985 New York
Board Certification
2014 Recertified, Infectious Diseases
2002 Recertified, Infectious Diseases (valid through 2014)
2002 Recertified, Internal Medicine
1994 Diplomate, American Board of Internal Medicine, Infectious Diseases
1992 Diplomate, American Board of Internal Medicine
Publications
Book Chapters and Reports
1. Baecher-Lind L, Wilcox A, Miller W. Infections and Reproduction. In Fertility and Pregnancy: An Epidemiologic Perspective, by Allen J Wilcox, Oxford University Press, 2010, pp 57-78.
2. Miller WC, Gay C. Fever of Unknown Origin. In Netter's Internal Medicine (MS Runge and MA Greganti, eds.), Saunders Elsevier, Philadelphia, PA, 2009, pp 637-643.
3. Miller WC, Juliano J. Malaria. In Netter's Internal Medicine (MS Runge and MA Greganti, eds.), Saunders Elsevier, Philadelphia, PA, 2009, pp 755-761.
3 CURRICULUM VITAE - William C. Miller
4. Miller WC. Fever of Unknown Origin. In Netter's Internal Medicine (MS Runge and MA Greganti, eds.), Icon Learning Systems, Teterboro, NJ, 2003, pp 481-486.
5. Miller WC. Malaria. In Netter's Internal Medicine (MS Runge and MA Greganti, eds.), Icon Learning Systems, Teterboro, NJ, 2003, pp 513-518.
6. Granger DL, Anstey NM, Miller WC, Weinberg JB. Measuring nitric oxide production in human clinical studies. In Nitric Oxide, Part C: Biological and Antioxidant Activities (L.Packer, ed), Academic Press, San Diego, CA. Methods in Enzymology 1998; 301: 49-61.
7. Granger DL, Miller WC, Hibbs J. Methods of analyzing nitric oxide production in the immune response. In Methods in Nitric Oxide Research (M. Feelisch and J. Stamler, eds.), John Wiley & Sons, Ltd. Sussex, UK, 1996, pp 603-617.
8. Miller WC, DeLong MR. Parkinsonian symptomatology: An anatomical and physiological analysis. In Central Determinants of Age-Related Declines in Motor Function (J.A. Joseph, ed.) New York Academy of Sciences, New York. Annals of the New York Academy of Science 1988; 515: 287-302.
9. Miller WC, DeLong MR, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In The Basal Ganglia II: Structure and Function - Current Concepts (M.B. Carpenter and A. Jayaraman, eds.) Plenum Press, New York. Advances in Behavioral Biology 1987; 32: 415-427.
Refereed Articles († student/trainee first authorship with primary advisory role)
1. Henegar CE, Westreich DJ, Maskew M, Miller WC, Brookhart MA, Van Rie A. The effect of pregnancy and the postpartum period on adherence to antiretroviral therapy among HIV-infected women established on treatment. J Acquir Immune Defic Syndr. 2014 Dec 31. [Epub ahead of print]
2. †72Davis NL, Miller WC, Hudgens MG, Chasela CS, Sichali D, Kayira D, Nelson JA, Stringer JS, Ellington SR, Kourtis AP, Jamieson DJ, van der Horst C; for the BAN study team. Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission. AIDS. 2014;28:2739-2749.
3. Henegar CE, Westreich D, Maskew M, Brookhart MA, Miller WC, Majuba P, Van Rie A. Comparison of pharmacy-based measures of adherence to antiretroviral therapy as predictors of virological failure. AIDS Behav. 2014 Nov 30. [Epub ahead of print]
4. O'Shea MS, Rosenberg NE, Hosseinipour MC, Stuart GS, Miller WC, Kaliti SM, Mwale M, Bonongwe PP, Tang JH. Effect of HIV status on fertility desire and knowledge of long-acting reversible contraception of postpartum Malawian women. AIDS Care. 2014; 4:1-10. [Epub ahead of print]
5. Escamilla V, Emch M, Dandalo L, Miller WC, Martinson F, Hoffman I. Sampling at community level by using satellite imagery and geographical analysis. Bull World Health Organ. 2014; 92:690-4. Epub 2014 Jun 17.
6. Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation. Pediatrics. 2014; 134:e1104-16.
4 CURRICULUM VITAE - William C. Miller
7. Weinberger M, Pusek SN, Esserman DA, Loehr LA, Miller WC, Orringer EP, Weaver MA. A model for developing, evaluating, and disseminating best practices in education and training. Clinical Translational Science. 2014; epub 22 July 2014.
8. †71Cholera R, Gaynes BN, Pence BW, Bassett J, Qangule N, Macphail C, Bernhardt S, Pettifor A, Miller WC. Validity of the patient health questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa. J Affect Disord. 2014;167C:160- 166.
9. †70Klein PW, Messer LC, Myers ER, Weber DJ, Leone PA, Miller WC. Impact of a routine, opt- out HIV testing program on HIV testing and case detection in North Carolina sexually transmitted disease clinics. Sex Transm Dis 2014; 41:395-402.
10. Rogers SM, Turner CF, Hobbs M, Miller WC, Tan S, Roman AM, Eggleston E, Villarroel MA, Ganapathi L, Chromy JR, Erbelding E. Epidemiology of undiagnosed trichomoniasis in a probability sample of urban young adults. PLoS One 2014;9:e90548. PMC3953116
11. Rogers SM, Turner CF, Miller WC, Erbelding E, Eggleston E, Tan S, Roman A, Hobbs M, Chromy J, Muvva R, Ganapathi L. Gender-based screening for chlamydial infection and divergent infection trends in men and women. PLoS One 2014;9:e89035.
12. Goswami ND, Tsalik EL, Naggie S, Miller WC, Horton JR, Pfeiffer CD, Hicks CB. A cross- sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design. Trials 2014;15:31. PMC3901894
13. †69Rosenberg NE, Kamanga G, Pettifor AE, Bonongwe N, Mapanje C, Rutstein SE, Ward M, Hoffman IF, Martinson F, Miller WC. STI patients are effective recruiters of undiagnosed cases of HIV: Results of a social contact recruitment study in Malawi. J Acquir Immune Defic Syndr 2014; 65:e162-9. PMC3999477
14. Phiri S, Zadrozny S, Weiss HA, Martinson F, Nyirenda N, Chen CY, Miller WC, Cohen MS, Mayaud P, Hoffman IF. Etiology of genital ulcer disease and association with HIV infection in Malawi. Sex Transm Dis. 2013;40:923-8.
15. Goswami ND, Stout JE, Miller WC, Hecker EJ, Cox GM, Norton BL, Sena AC. The footprint of old syphilis: Using a reverse screening algorithm for syphilis testing in a US geographic information systems-based community outreach program. Sex Transm Dis. 2013;40:839-841.
16. Adimora AA, Schoenbach VJ, Taylor EM, Khan MR, Schwartz RJ, Miller WC. Sex ratio, poverty, and concurrent partnerships among men and women in the United States: a multilevel analysis. Ann Epidemiol. 2013; 23:716-9 [Oct 5. Epub ahead of print]
17. McCormick D, Rahman M, Zadrozny S, Alam A, Ashraf L, Neilsen G, Kelly R, Menezes P, Miller WC, Hoffman IF. Prevention and control of STIs among hotel-based female sex workers in Dhaka, Bangladesh. Sexual Health 2013; 10:478-86. [Oct 11. Epub ahead of print]
18. Fiscus SA, McMillion T, Nelson JA, Miller WC. Validation of the Gen-Probe Aptima Qualitative HIV-1 RNA for diagnosis of human immunodeficiency virus infection in infants. J Clin Microbiol. 2013; 51:4137-4140. [Oct 2. Epub ahead of print] PMC3838099
19. Rosenberg NE, Westreich D, Bärnighausen T, Miller WC, Behets F, Maman S, Newell ML, Pettifor A. Assessing the effect of HIV counselling and testing on HIV acquisition among South African youth. AIDS. 2013; 7:2765-73 [Jul 24. Epub ahead of print]
5 CURRICULUM VITAE - William C. Miller
20. Olson D, Davis NL, Milazi R, Lufesi N, Miller WC, Preidis GA, Hosseinipour MC, McCollum ED. Development of a severity of illness scoring system (inpatient triage, assessment and treatment) for resource-constrained hospitals in developing countries. Trop Med Int Health 2013; 18:871-8. doi: 10.1111/tmi.12137.
21. Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013; 13:459-64 Mar 25. doi:pii: S1473-3099(12)70314-6.
22. †68Rutstein SE, Brown LB, Biddle AK, Wheeler SB, Kamanga G, Mmodzi P, Nyirenda N, Mofolo I, Rosenberg NE, Hoffman IF, Miller WC. Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy & Planning 2013; 140: 1-12. PMC3872371
23. Gesink DC, Sullivan AB, Norwood TA, Serre ML, Miller WC. Does core area theory apply to sexually transmitted diseases in rural environments? Sex Transm Dis. 2013; 40:32-40. PMC3528791
24. †67Rosenberg NE, Pettifor AE, De Bruyn G, Westreich D, Delany-Moretlwe S, Behets F, Maman S, Coetzee D, Kamupira M, Miller WC. HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples. J Acquir Immune Defic Syndr. 2013: 62:226-33. [Epub ahead of print, 2012 Oct 31.] PMC3548982
25. †66Atashili J, Miller WC, Smith JS, Ndumbe PM, Ikomey GM, Eron J, Rinas AC, Myers E, Adimora AA. Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study. BMC Res Notes. 2012 Oct 29;5(1):590. [Epub ahead of print] PMID: 23106940; PMC3505154
26. Doherty IA, Serre ML, Gesink D, Adimora AA, Muth SQ, Leone PA, Miller WC. Sexual networks, surveillance, and geographical space during syphilis outbreaks in rural North Carolina. Epidemiology. 2012; 23:845-51. [Epub ahead of print, Sep. 21]; PMC4074028
27. HIV Modelling Consortium Treatment as Prevention Editorial Writing Group. HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. PLoS Med. 2012;9(7):e1001259
28. Smith MK, Powers KA, Muessig KE, Miller WC, Cohen MS. HIV treatment as prevention: The utility and limitations of ecological observation. PLoS Med. 2012;9(7):e1001260. Epub 2012 Jul 10. PMC3393666
29. Cohen MS, Dye C, Fraser C, Miller WC, Powers KA, Williams BG. HIV treatment as prevention: Debate and commentary-will early infection compromise treatment-as-prevention strategies? PLoS Med. 2012;9(7):e1001232. Epub 2012 Jul 10. PMC3393667
30. Keating MA, Hamela G, Miller WC, Moses A, Hoffman IF, Hosseinipour MC. High HIV incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: Implications for the risk of HIV acquisition. PLoS One. 2012;7(6):e39109. Epub 2012 Jun 29 PMC3387180
31. Gaynes BN, Dusetzina SB, Ellis AR, Hansen RA, Farley JF, Miller WC, Stürmer T. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. J Clin Psychopharmacol. 2012;32:114-9.
32. Makoka MH, Miller WC, Hoffman IF, Cholera R, Gilligan PH, Kamwendo D, Malunga G, Joaki G, Martinson F, Hosseinipour MC. Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance. BMC Infect Dis. 2012 Mar 21;12(1):67. [Epub ahead of print] PMC3342226
6 CURRICULUM VITAE - William C. Miller
33. Samuel JC, Sankhulani E, Qureshi JS, Baloyi P, Thupi C, Lee CN, Miller WC, Cairns BA, Charles AG. Under-reporting of road traffic mortality in developing countries: application of a capture-recapture statistical model to refine mortality estimates. PLoS One. 2012;7(2):e31091. Epub 2012 Feb 15. PMC3280223
34. Rogers SM, Khan MR, Tan S, Turner CF, Miller WC, Erbelding E. Incarceration, high-risk sexual partnerships and sexually transmitted infections in an urban population. Sex Transm Infect. 2012; 88:63-8.
35. †65Hoots BE, MacDonald PD, Hightow-Weidman LB, Leone PA, Miller WC. Developing a predictive model to prioritize human immunodeficiency virus partner notification in North Carolina. Sex Transm Dis. 2012;39:65-71. PMC3244826
36. †64Rosenberg NE, Kamanga G, Phiri S, Nsona D, Pettifor A, Rutstein SE, Kamwendo D, Hoffman IF, Keating M, Brown LB, Ndalama B, Fiscus SA, Congdon S, Cohen MS, Miller WC. Detection of acute HIV infection: A field evaluation of the Determine(R) HIV-1/2 Ag/Ab Combo Test. J Infect Dis. 2012; 205:528-34 [2011 Dec 29. Epub ahead of print] PMC3318673
37. †63Brown LB, Miller WC, Kamanga G, Kaufman JS, Pettifor A, Dominik R, Nyirenda N, Mmodzi P, Mapanje C, Martinson F, Cohen MS, Hoffman IF. Predicting partner HIV testing and counseling following a partner notification intervention. AIDS & Behavior 2012;16:1148-55; PMC3515685
38. †62Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, Eron J, Smith JS, Miller WC. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? Cancer Epidemiol. 2012;36:263-9. Epub 2011 Nov 1; PMC3288586
39. Kissin DM, Mandel MG, Akatova N, Belyakov NA, Rakhmanova AG, Voronin EE, Volkova GV, Yakovlev AA, Jamieson DJ, Vitek C, Robinson J, Miller WC, Hillis S. Five-year trends in epidemiology and prevention of mother-to-child HIV transmission, St. Petersburg, Russia: results from perinatal HIV surveillance. BMC Infect Dis. 2011;11:292. [Epub ahead of print] PMC3229516
40. †61Guderian LJ, Miller WC, Seña AC, Stout JE. Increased prevalence of advanced tuberculosis in rural low tuberculosis caseload counties in North Carolina. Int J Tuberc Lung Dis. 2011;15:1455-61.
41. Hampton KH, Serre ML, Gesink DC, Pilcher CD, Miller WC. Adjusting for sampling variability in sparse data: geostatistical approaches to disease mapping. Int J Health Geogr. 2011;10:54. [Epub ahead of print] PMC3204220
42. Gaynes BN, Farley JF, Dusetzina SB, Ellis AR, Hansen RA, Miller WC, Stürmer T. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression? Depress Anxiety. 2011; 28:989-98 Sep 2. doi: 10.1002/da.20898. [Epub ahead of print] PMC32115789
43. Pettifor AE, Levandowski BA, Macphail C, Miller WC, Tabor J, Ford C, Stein CR, Rees H, Cohen M. A tale of two countries: Rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health 2011;49:237-243.e1. Epub 2011 Mar 23 PMC3159866
7 CURRICULUM VITAE - William C. Miller
44. Eggleston E, Rogers SM, Turner CF, Miller WC, Roman AM, Hobbs MM, Erbelding E, Tan S, Villarroel MA, Ganapathi L. Chlamydia trachomatis infection among 15- to 35-Year-Olds in Baltimore, MD. Sex Transm Dis. 2011;38:743-749 PMC3190190
45. Bischof JJ, Kuruc JD, Embry JA, Hatch JE, Ashton FA, Schmitz JL, Miller WC, Leone PA, Gay CL. Prospective Study of the ARCHITECTHIV Ag/Ab Combo 4th generation assay to detect HIV infection in STI clinics. AIDS. 2011; 25:1927-9 Epub 2011 Aug 1.
46. Weiss HA, Paz Bailey G, Phiri S, Gresenguet G, Legoff J, Pepin J, Lewis DA, Belec L, Hoffman IF, Miller WC, Mayaud P. Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials. PLoS One. 2011;6:e22601. Epub 2011 Jul 25. PMC3143155
47. †60Menezes P, Miller WC, Wohl DA, Adimora AA, Leone PA, Eron JJ Jr. Does HAART efficacy translate to effectiveness? Evidence for a trial effect. PLoS One. 2011;6(7):e21824. Epub 2011 Jul 13. PMC3135599
48. †59Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, Martinson FEA, Cohen MS. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modeling study. Lancet 2011; 378:256- 68. [Epub ahead of print, Jun 17]. PMC3274419
49. Gesink DC, Sullivan AB, Miller WC, Bernstein KT. Sexually transmitted disease core theory: Roles of person, place, and time. Am J Epidemiol. 2011; 174:81-9. E-pub 2011 May 3. PMC3159428
50. †58Atashili J, Smith JS, Adimora AA, Eron J, Miller WC, Myers E. Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in Sub-Saharan Africa: A Simulation. PLoS One. 2011 Apr 4;6(4):e18527. PMC3070738
51. †57Brown LB, Miller WC, Kamanga G, Nyirenda N, Mmodzi P, Pettifor A, Dominik R, Kaufman JS, Mapanje C, Martinson F, Cohen MS, Hoffman IF. HIV partner notification is effective and feasible in sub-Saharan Africa: Opportunities for improved HIV treatment and prevention. JAIDS – Journal of Acquired Immune Deficiency Syndromes 2011; 56: 437-442. PMC3207356
52. Sullivan AB, Gesink DC, Brown P, Zhou L, Kaufman JS, Fitch M, Serre ML, Miller WC. Are neighborhood sociocultural factors influencing the spatial pattern of gonorrhea in North Carolina? Ann Epidemiol. 2011;21:245-52. PMC3057378
53. †56Powers KA, Hoffman IF, Ghani AC, Hosseinipour MC, Pilcher CD, Price MA, Pettifor AE, Chilongozi DA, Martinson FE, Cohen MS, Miller WC. Sexual partnership patterns in Malawi: Implications for HIV/STI transmission. Sex Transm Dis. 2011;38:657-666. [Epub ahead of print Feb 4.] PMC3125407
54. Doherty IA, Adimora AA, Muth SQ, Serre ML, Leone PA, Miller WC. Comparison of sexual mixing patterns for syphilis in endemic and outbreak settings. Sex Transm Dis. 2011; 38:378- 384. Epub: 2011 Jan 6.
55. Taylor EM, Behets FM, Schoenbach VJ, Miller WC, Doherty IA, Adimora AA. Coparenting and sexual partner concurrency among white, black, and Hispanic men in the United States. Sex Transm Dis. 2011;38:293-8. Epub: 2010 Oct 29.
56. Pettifor A, Macphail C, Corneli A, Sibeko J, Kamanga G, Rosenberg N, Miller WC, Hoffman I, Rees H, Cohen MS; NIAID Center for HIV/AIDS Vaccine Immunology. Continued high risk
8 CURRICULUM VITAE - William C. Miller
sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: Implications for Prevention. AIDS Behav. 2011; 15:1243-50. Epub: 2010 Oct 27. [Epub ahead of print] PMC3530889
57. †55Menezes P, Eron JJ Jr, Leone PA, Adimora AA, Wohl DA, Miller WC. Recruitment of HIV/AIDS treatment-naïve patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race. HIV Med. 2011; 12:183-91. epub: 2010; Aug 29. [Epub ahead of print]
58. Xue J, Mhango Z, Hoffman IF, Mofolo I, Kamanga E, Campbell J, Allgood G, Cohen MS, Martinson FE, Miller WC, Hosseinipour MC. Use of nutritional and water hygiene packages for diarrhoeal prevention among HIV-exposed infants in Lilongwe, Malawi: an evaluation of a pilot prevention of mother-to-child transmission post-natal care service. Trop Med Int Health. 2010; 15:1156-62. Jul 30. [Epub ahead of print]
59. †54McCoy SI, Jones B, Leone PA, Napravnik S, Quinlivan EB, Eron JJ, Miller WC. Variability of the date of HIV diagnosis: A comparison of self-report, medical record, and HIV/AIDS surveillance data. Ann Epidemiol. 2010; 20:734-42 [Jul 9. Epub ahead of print]
60. Hampton KH, Fitch MK, Allshouse WB, Doherty IA, Gesink DC, Leone PA, Serre ML, Miller WC. Mapping health data: Improved privacy protection with donut method geomasking. American Journal of Epidemiology 2010; 172:1062-9 [Sep 3 Epub ahead of print]. PMC2984253
61. Allshouse WB, Fitch MK, Hampton KH, Gesink DC, Doherty IA, Leone PA, Serre ML, Miller WC. Geomasking sensitive health data and privacy protection: an evaluation using an E911 database. Geocarto International 2010; 25: 443-452. NIHMS219832, PMC2952889
62. Phiri S, Hoffman IF, Weiss HA, Martinson F, Nyirenda N, Kamwendo D, Fiscus SA, Chen CY, Miller WC, van der Hoeven L, Chilongozi D, Cohen MS, Mayaud P. Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi. Sex Transm Infect. 2010; 86(5):345-52. [May 5. Epub ahead of print]
63. Deveaugh-Geiss AM, West SL, Miller WC, Sleath B, Gaynes BN, Kroenke K. The adverse effects of comorbid pain on depression outcomes in primary care patients: Results from the ARTIST trial. Pain Med. 2010; 11:732-41. [Mar 26. Epub ahead of print]
64. Hillis SD, Kuklina E, Akatova N, Kissin DM, Vinogradova EN, Rakhmanova AG, Stepanova E, Jamieson DJ, Robinson J, Vitek C, Miller WC. Antiretroviral prophylaxis to prevent perinatal HIV transmission in St. Petersburg, Russia: Too little, too late. J Acquir Immune Defic Syndr. 2010; 54:304-10.
65. DeVeaugh-Geiss AM, West SL, Miller WC, Sleath B, Kroenke K, Gaynes BN. Depression and comorbid panic in primary care patients. J Affect Disord. 2010; 123:283-90. Epub 2009 Oct 13
66. †53McCoy SI, Strauss RP, Macdonald PD, Leone PA, Eron JJ, Miller WC. Social support and delays seeking care after HIV diagnosis, North Carolina, 2000-2006. AIDS Care. 2009;21:1148- 56.
67. †52McCoy SI, Miller WC, Macdonald PD, Hurt CB, Leone PA, Eron JJ, Strauss RP. Barriers and facilitators to HIV testing and linkage to primary care: narratives of people with advanced HIV in the Southeast. AIDS Care. 2009;21:1313-20.
9 CURRICULUM VITAE - William C. Miller
68. Pettifor A, Delany S, Kleinschmidt I, Miller WC, Atashili J, Rees H. Use of injectable progestin contraception and risk of STI among South African women. Contraception. 2009;80:555-60. PMC2902790
69. Pettifor A, O'Brien K, Macphail C, Miller WC, Rees H. Early coital debut and associated HIV risk factors among young women and men in South Africa. Int Perspect Sex Reprod Health. 2009; 35:82-90.
70. Samuel JC, Akinkuotu A, Villaveces A, Charles AG, Lee CN, Hoffman IF, Miller WC, Baloyi P, Hoffman M, Brown LB, Muyco AP. Epidemiology of injuries at a tertiary care center in Malawi. World J Surg. 2009;33:1836-41.
71. Khan MR, Kaufman JS, Pence BW, Gaynes BN, Adimora AA, Weir SS, Miller WC. Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med. 2009;163:644-52. PMC2796823
72. Fetzer BC, Hosseinipour MC, Kamthuzi P, Hyde L, Bramson B, Jobarteh K, Torjesen K, Miller WC, Hoffman I, Kazembe P, Mwansambo C. Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi. Trop Med Int Health. 2009;14:862-9. PMC2892779
73. †51Torok MR, Miller WC, Hobbs MM, Macdonald PD, Leone PA, Schwebke JR, Seña AC. The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis. Sex Transm Dis. 2009; 36:336-40.
74. Pence BW, Miller WC, Gaynes BN. Prevalence estimation and validation of new instruments in psychiatric research: An application of latent class analysis and sensitivity analysis. Psychol Assess. 2009; 21:235-9. PMC2855555
75. †50McCoy SI, Eron JJ, Kuruc JD, Strauss RP, Macdonald PD, Fiscus SA, Barnhart J, Pilcher CD, Leone PA, Miller WC. Sexually transmitted infections among patients with acute HIV in North Carolina. Sex Transm Dis. 2009; 36:372-374. PMC2708082
76. †49Norris Turner A, Miller WC, Padian NS, Kaufman JS, Behets FM, Chipato T, Mmiro FA, Salata RA, Morrison CS. Unprotected sex following HIV testing among women in Uganda and Zimbabwe: short- and long-term comparisons with pre-test behavior. Intl. J. Epidemiol. 2009;38:997-1007. PMC2720394
77. Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams D, Pilcher CD. Targeted testing for acute HIV infection in North Carolina. AIDS 2009; 27:835-43. NIHMS175335, PMC2828678
78. Ford CL, Daniel M, Earp JL, Kaufman JS, Golin CE, Miller WC. Perceived everyday racism, residential segregation, and HIV testing among patients at a sexually transmitted disease clinic. Am J Public Health. 2009; 99 Suppl 1:S137-43. PMC2724930
79. †48Desai MN, Miller WC, Staples B, Bravender T. Risk factors associated with overweight and obesity in college students. J Am Coll Health. 2008;57:109-14.
80. †47Stein CR, Kaufman JS, Ford CA, Leone PA, Feldblum PJ, Miller WC. Screening young adults for prevalent chlamydial infection in community settings. Ann Epidemiol. 2008; 18: 560-571. PMC2490822.
81. †46Nguyen TQ, Ford CA, Kaufman JS, Leone PA, Suchindran C, Miller WC. Infrequent chlamydial testing among young adults: Financial and regional differences. Sex Transm Dis. 2008; 35:725-730.
10 CURRICULUM VITAE - William C. Miller
82. †45Stein CR, Kaufman JS, Ford CA, Feldblum PJ, Leone PA, Miller WC. Partner age difference and prevalence of chlamydial infection among young adult women. Sex Transm Dis. 2008; 35: 447–452.
83. †44Norris Turner A, Morrison CS, Padian NS, Kaufman JS, Behets FM, Salata RA, Mmiro FA, Chipato T, Celentano DD, Rugpao S, Miller WC. Male circumcision and women's risk of incident chlamydial, gonococcal, and trichomonal infections. Sex Transm Dis. 2008; 35:689-695. PMC2978019
84. †43Al-Tayyib AA, Miller WC, Rogers SM, Leone PA, Gesink Law DC, Ford CA, Ellen JM. Health care access and follow-up of chlamydial and gonococcal infections identified in an emergency department. Sex Transm Dis. 2008; 35:583-7.
85. †42Khan MR, Miller WC, Schoenbach VJ, Weir SS, Kaufman JS, Wohl DA, Adimora AA. Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol. 2008; 18:403-10. PMC2877367
86. Gaynes BN, Pence BW, Eron JJ Jr, Miller WC. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med. 2008; 70: 505-11. PMC2900836
87. †41Ito KE, Kalyanaraman S, Ford CA, Brown JD, Miller WC. "Let's Talk About Sex": Pilot study of an interactive CD-ROM to prevent HIV/STIS in female adolescents. AIDS Educ Prev. 2008;20(1):78-89.
88. Kissin DM, Akatova N, Rakhmanova AG, Vinogradova EN, Voronin EE, Jamieson DJ, Glynn MK, Yakovlev A, Robinson J, Miller WC, Hillis S. Rapid HIV testing and prevention of perinatal HIV transmission in high-risk maternity hospitals in St. Petersburg, Russia. Am J Obstet Gynecol. 2008;198:183.e1-7.
89. †40Al-Tayyib AA, Miller WC, Rogers SM, Leone PA, Law DC, Ford CA, Rothman RE. Evaluation of risk score algorithms for detection of chlamydial and gonococcal infections in an emergency department setting. Acad Emerg Med. 2008;15:126-135.
90. †39Khan MR, Wohl DA, Weir SS, Adimora AA, Moseley C, Norcott K, Duncan J, Kaufman JS, Miller WC Incarceration and risky sexual partnerships in a southern US city. J Urban Health. 2008;85:100-13; Epub 2007 Nov 20. PMC2430135
91. Rogers SM, Miller WC, Turner CF, Ellen J, Zenilman J, Rothman R, Villarroel M, Al-Tayyib AA, Leone P, Gaydos C, Ganapathi L, Hobbs M, Kanouse D. Concordance of Chlamydia trachomatis infections within sexual partnerships. Sex Transm Infect. 2008;84:23-8. Epub 2007 Oct 2.
92. †38Powers KA, Miller WC, Pilcher CD, Mapanje C, Martinson FE, Fiscus SA, Chilongozi DA, Namakhwa D, Price MA, Galvin SR, Hoffman IF, Cohen MS; Malawi UNC Project Acute HIV Study Team. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS. 2007 Oct 18;21(16):2237-42. PMC2673577
93. †37Torok MR, Miller WC, Hobbs MM, MacDonald PD, Leone PA, Schwebke JR, Seña AC, The association between Trichomonas vaginalis infection and level of vaginal lactobacilli among non- pregnant women. Journal of Infectious Diseases 2007; 196:1102-1107.
94. †36Norris Turner A, Morrison CS, Padian NS, Kaufman JS, Salata RA, Chipato T, Mmiro FA, Mugerwa RD, Behets FM, Miller WC. Men’s circumcision status and women’s risk of HIV acquisition in Zimbabwe and Uganda. AIDS 2007; 21: 1779-1789. PMC2978032
11 CURRICULUM VITAE - William C. Miller
95. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Miller WC, Hobbs MM. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis. 2007; 45:194-8. Epub 2007 Jun 6.
96. †35Wallace DK, Veness-Meehan KA, Miller WC. Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels. Journal of the American Association for Pediatric Ophthalmology and Strabismus 2007;11:170-174. PMC2705933
97. Ford CL, Miller WC, Smurzynski M, Leone PA. Key components of a theory-guided HIV prevention outreach model: pre-outreach preparation, community assessment, and a network of key informants. AIDS Educ Prev. 2007; 19:173-86.
98. Hillis SD, Rakhmanova A, Vinogradova E, Voronin E, Yakovlev A, Khaldeeva N, Akatova N, Samarskaya M, Volkova G, Kissin D, Jamieson DJ, Glynn MK, Robinson J, Miller WC. Rapid HIV testing, pregnancy, antiretroviral prophylaxis and infant abandonment in St Petersburg. Int J STD AIDS. 2007; 18:120-2.
99. Huang X, Chen H, Miller WC, Mailman RB, Woodard JL, Chen PC, Xiang D, Murrow RW, Wang YZ, Poole C. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord. 2007; 22:377-81. PMC1906875
100. Fiscus SA, Pilcher CD, Miller WC, Powers KA, Hoffman IF, Price M, Chilongozi DA, Mapanje C, Krysiak R, Gama S, Martinson FEA, Cohen MS, and the Malawi-UNC Project AHI Study Team. Rapid, real-time detection of patients with acute HIV infection in Africa. Journal of Infectious Diseases 2007; 195:416-24.
101. Hallfors DD, Iritani B, Miller WC, Bauer DJ. Do sex and drug behavior patterns account for HIV/STD racial disparities? American Journal of Public Health 2007; 97:125-32. PMC1716241
102. Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS. Trichomonas vaginalis infection in male sexual partners: Implications for diagnosis, treatment and prevention. Clinical Infectious Diseases 2007; 44:13-22.
103. †34Pence BW, Miller WC, Gaynes BN, Eron JJ, Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007; 44:159- 66.
104. Iritani BJ, Ford CA, Miller WC, Hallfors DD, Halpern CT. Comparison of self-reported and test- identified chlamydial infections among young adults in the United States of America. Sexual Health 2006; 3:245-251.
105. Hobbs MM, Lapple D, Lawing LF, Schwebke JR, Cohen MS, Swygard H, Atashili J, Leone PA, Miller WC, Seña AC. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. Journal of Clinical Microbiology 2006; 44:3994-3999. PMC1698299
106. †33Ito KE, Gizlice Z, Owen-O'dowd J, Foust E, Leone PA, Miller WC. Parent opinion of sexuality education in a state with mandated abstinence education: Does policy match parental preference? J Adolesc Health. 2006; 39:634-641.
107. Sotir M, Yeatts K, Miller W, Shy C. Comparison of asthma-related functional consequences and health care utilization among children with and without upper respiratory infection-triggered wheezing. J Asthma. 2006;43:629-32
12 CURRICULUM VITAE - William C. Miller
108. Price MA, Stewart SR, Miller WC, Behets F, Dow WH, Martinson FEA, Chilongozi D, Cohen MS. The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking STD care in Malawi. J Acquir Immune Defic Syndr. 2006; 43:202-209.
109. †32Joos T, Miller WC, Murdoch D. Tuberculin reactivity in Bacille Calmette-Guerin vaccinated populations: A compilation of international data. The International Journal of Tuberculosis and Lung Disease 2006; 10:883-891.
110. Law DCG, Bernstein KT, Serre ML, Schumacher CM, Leone PA, Zenilman JM, Miller WC, Rompalo AM. Modeling a syphilis outbreak through space and time using the Bayesian Maximum Entropy approach. Ann Epidemiol. 2006; 16:797-804.
111. Ford CL, Daniel M, Miller WC. High rates of human immunodeficiency virus (HIV) testing despite low perceived HIV risk among African American sexually transmitted disease patients. Journal of the National Medical Association 2006; 98:841-844. PMC2569408
112. Morris M, Handcock MS, Miller WC, Ford CA, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR. Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health. 2006; 96:1091-1097. PMC1470623
113. †31Nguyen TQ, Ford CA, Kaufman JS, Leone PA, Suchindran C, Miller WC. HIV testing among young adults in the United States: associations with financial resources and geography. Am J Public Health. 2006; 96:1031-1034. PMC1470638
114. †30Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr. 2006; 42:298-306.
115. Shimokura G, Weber DJ, Miller WC, Wurtzel H, Alter MJ. Factors associated with personal protection equipment use and hand hygiene among hemodialysis staff. Am J Infect Control. 2006; 34:100-7.
116. Kozlov AP, Shaboltas AV, Toussova OV, Verevochkin SV, Masse BR, Perdue T, Beauchamp G, Sheldon W, Miller WC, Heimer R, Ryder RW, Hoffman IF. HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS. 2006; 20:901- 906.
117. Hooshyar D, Napravnik S, Miller WC, Eron JJ Jr. Effect of hepatitis C co-infection on discontinuation and modification of initial highly active antiretroviral therapy in primary HIV care. AIDS 2006; 20:575-83.
118. Yakubovsky A, Sokolovsky E, Miller WC, Sparling PF, Ryder RW, Hoffman IF. Syphilis management in St. Petersburg, Russia: 1995-2001. Sexually Transmitted Diseases 2006; 33:244-249.
119. Kwiek JJ, Mwapasa V, Milner, DA Jr., Alker AP, Miller WC, Tadesse E, Molyneux ME, Rogerson SJ, Meshnick SR. Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi. PloS Medicine 2005; 3:e10 (6 pages). PMC1285069
120. †29Pence BW, Gaynes BN, Whetten K, Eron JJ Jr, Ryder RW, Miller WC. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. Journal of Acquired Immune Deficiency Syndromes 2005; 40: 434-444.
13 CURRICULUM VITAE - William C. Miller
121. Coeytaux RR, Kaufman JS, Kaptchuk TJ, Chen W, Miller WC, Callahan LF, Mann JD. A randomized, controlled trial of acupuncture for chronic daily headache. Headache 2005; 45: 1113-1123.
122. Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, Schmitz JL, Cohen MS, Harris K Mullan, Udry JR. The prevalence of trichomoniasis in young adults in the United States. Sexually Transmitted Diseases 2005; 32:593-598.
123. †28Sarmiento OL, Miller WC, Ford CA, Schoenbach VJ, Adimora AA, Viadro CI, Suchindran CM. Routine physical examination and foregone health care among Latino adolescent immigrants in the United States. Journal of Immigrant Health 2005; 7:309-316.
124. †27Patnaik P, Jere CS, Miller WC, Hoffman IF, Wirima J, Pendame R, Meshnick SR, Taylor TE, Molyneux ME Kublin JG. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. Journal of Infectious Diseases 2005; 192: 984-991.
125. †26Odetola FO, Miller WC, Davis MM, Bratton SL. The relationship between the location of paediatric intensive care facilities and child mortality from trauma: A county-level ecologic study. The Journal of Pediatrics 2005;147:74-7.
126. Ford CA, Pence BW, Miller WC, Resnick MD, Bearinger LH, Pettingell S, Cohen M. Predicting adolescents' longitudinal risk for sexually transmitted infections: Results from the National Longitudinal Study of Adolescent Health. Arch Pediatr Adolesc Med 2005; 159:657-64.
127. Williams RE, Hartmann KE, Sandler RS, Miller WC, Savitz LA, Steege JF. Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol Surv. 2005;60:439-440.
128. Krobot KJ, Kaufman JS, Christensen DB, Preisser JS, Miller WC, Ibrahim MA. Accessing a new medication in Germany: a novel approach to assess a health insurance-related barrier. Ann Epidemiol. 2005 15:756-761.
129. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, Ashby R, Owen-O’Dowd J, McPherson JT, Stalzer B, Hightow L, Miller WC, Eron JJ, Jr., Cohen MS, Leone PA. Detection of acute infections during HIV testing in North Carolina. New England Journal of Medicine 2005; 352: 1873-83.
130. Rosenthal MS, Lannon CM, Stuart JM, Brown L, Miller WC, Margolis PA. A randomized trial of practice-based education to improve delivery systems for anticipatory guidance. Arch Pediatr Adolesc Med. 2005; 159:456-463.
131. †25McPheeters ML, Miller WC, Hartmann KE, Savitz DA, Kaufman JS, Garrett JM, Thorp JM. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol. 2005; 192:1325-9
132. Kaestle CE, Halpern CT, Miller WC, Ford CA. Early sexual debut and sexually transmitted infections in adolescents and young adults. American Journal of Epidemiology 2005; 161: 774- 780.
133. Williams RE, Hartmann KE, Sandler RS, Miller WC, Savitz LA, Steege JF. Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. American Journal of Obstetrics and Gynecology 2005; 192:761-767.
14 CURRICULUM VITAE - William C. Miller
134. †24Gourlay ML, Miller WC, Richy F, Garrett JM, Hanson LC, Reginster J-Y. Performance of osteoporosis risk assessment tools in postmenopausal women aged 45 to 64 years. Osteoporosis International 2005; 16:921-7.
135. Purves H, Pietrobon R, Hervey S, Guller U, Miller W, Ludwig K. Relationship between surgeon caseload and sphincter preservation in patients with rectal cancer. Diseases of Colon & Rectum 2005; 48:195-204.
136. Eggleston E, Turner C, Rogers SM, Roman A, Miller WC, Villarroel M, Ganapathi L. Monitoring STI prevalence using telephone surveys and mailed urine specimens: A pilot test. Sexually Transmitted Infections 2005; 81:236-238.
137. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Pendame R, Taylor TE, Molyneux ME. Effect of Plasmodium falciparum malaria on HIV-1 RNA blood concentration in a cohort of adults in rural Malawi. Lancet 2005; 365:233-240.
138. Ford CA, Jaccard J, Millstein SG, Bardsley PE, Miller WC. Perceived risk of chlamydial and gonococcal infection among sexually experienced young adults in the United States. Perspectives on Sexual and Reproductive Health 2004; 36:258-264.
139. †23Fiscus LC, Ford CA, Miller WC. Infrequency of STD screening among sexually experienced female adolescents in the United States. Perspectives on Sexual and Reproductive Health 2004; 36:233-238.
140. Meltzer-Brody S, Hartmann KE, Miller WC, Scott J, Garrett J, Davidson J. A brief screening instrument to detect posttraumatic stress disorder in outpatient gynecology. Obstetrics and Gynecology 2004; 104:770-776.
141. †22Swygard H, Miller WC, Kaydos SC, Leone PA, Cohen MS, Hobbs MM, Seña AC. Targeted screening for Trichomonas vaginalis with culture using a two step method in women presenting for STD evaluation. Sexually Transmitted Diseases 2004; 31: 659-664.
142. †21Price MA, Miller WC, Kaydos-Daniels SC, Hoffman IF, Chilongozi D, Martinson FE, Namakhwa D, Malanda J, Cohen MS. Male trichomoniasis and HIV infection: data from two outpatient clinics in the Lilongwe Central Hospital, Malawi. J Infect Dis 2004; 190:1448-1455.
143. †20Newbern EC, Miller WC, Schoenbach VJ, Kaufman JS. Family socioeconomic status and self- reported sexually transmitted diseases among black and white American adolescents. Sexually Transmitted Diseases 2004; 31: 533-541.
144. †19Sarmiento OL, Miller WC, Ford CA, Schoenbach VJ, Viadro CI, Adimora AA, Suchindran CM. Disparities in routine physical examinations among in-school adolescents of differing Latino origins. Journal of Adolescent Health 2004; 35:310-320.
145. Perrin EM, Murphy ML, Casey J, Pichichero ME, Runyan DK, Miller WC, Snider LA, Swedo SE. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Archives of Pediatrics and Adolescent Medicine 2004; 158:848-856.
146. Williams RE, Hartmann KE, Sandler RS, Miller WC, Steege JF. Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstetrics and Gynecology 2004; 104:452-458.
15 CURRICULUM VITAE - William C. Miller
147. †18Law DCG, Serre ML, Christakos G, Leone PA, Miller WC. Spatial analysis and mapping of sexually transmitted diseases to optimize intervention and prevention strategies. Sex Transm Infect 2004; 80:294-299.
148. †17Hightow LB, Miller WC, Leone PA, Wohl DA, Smurzynski M, Kaplan AH. Predictors of repeat testing and HIV seroconversion in a sexually transmitted disease clinic population. Sex Transm Dis 2004; 31: 455-459.
149. Tilson EC, Sanchez V, Ford CL, Smurzynski M, Leone PA, Fox KK, Irwin K, Miller WC. Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions. BMC Public Health 2004; 4:21. http://www.biomedcentral.com/1471- 2458/4/21/ (24 pages). PMC436061
150. †16Kaydos-Daniels SC, Miller WC, Hoffman I, Price MA, Martinson F, Chilongozi D, Namakhwa D, Gama S, Phakati S, Cohen MS, Hobbs MM. Detection of Trichomonas vaginalis infection from various genitourinary sites in men. Journal of Infectious Diseases 2004; 189: 1926-1931.
151. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris K Mullan, Udry JR. Prevalence of chlamydial and gonococcal infection among young adults in the United States. JAMA 2004; 291: 2229-2236.
152. Krobot KJ, Miller WC, Kaufman JS, Christensen DB, Preisser JS, Ibrahim MA. The disparity in access to new medication by type of health insurance: Lessons from Germany. Medical Care 2004; 42: 487-491.
153. Ford CA, Jaccard J, Millstein SG, Viadro CI, Eaton JL, Miller WC. Young adults' attitudes, beliefs, and feelings about testing for curable STDs outside of clinic settings. Journal of Adolescent Health 2004; 34: 266-269.
154. Pilcher CD, Price MA, Hoffman IF, Galvin S, Martinson FEA, Kazembe PN, Eron JJ, Miller WC, Fiscus SA, Cohen MS. Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004; 18: 517-524.
155. Orton SM, Peace-Brewer A, Schmitz JL, Freeman K, Miller WC, Folds JD. Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens. Clinical and Diagnostic Laboratory Immunology 2004; 11:197-301. PMC371197
156. Krobot KJ, Miller WC, Kaufman JS, Christensen DB, Preisser JS, Ibrahim MA. Quantifying delay in access to new medical treatment: An application of risk advancement period methodology. Epidemiology 2004; 15:202-207.
157. Corbie-Smith G, Miller WC, Ransohoff DF. Interpretations of 'appropriate' minority inclusion in clinical research. Am J Med 2004; 116:249-252.
158. Ford CA, Viadro CI, Miller WC. Testing for chlamydial and gonorrheal infections outside of clinic settings: A summary of the literature. Sexually Transmitted Diseases 2004; 31:38-51.
159. †15Benjamin DK Jr., Miller WC, Ryder RW, Weber DJ, Walter E, McKinney RE Jr. Growth patterns reflect response to antiretroviral therapy in HIV positive infants: potential utility in resource-poor settings. AIDS Patient Care and STDs 2004;18:35-43.
160. †14Benjamin DK Jr, Miller WC, Benjamin DK, Ryder RW, Weber DJ, Walter E, McKinney RE Jr. A comparison of height and weight velocity to predict laboratory and clinical progression in pediatric HIV AIDS 2003; 17:2331-2336.
16 CURRICULUM VITAE - William C. Miller
161. †13Sarmiento OL, Weigle K, Alexander J, Weber DJ, Miller WC. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. Journal of Clinical Microbiology 2003; 41:3233-40. PMC165327
162. †12Hightow LB, Miller WC, Leone PA, Wohl DA, Smurzynski M, Kaplan A. Failure to return for HIV posttest counseling in an STD clinic population. AIDS Education and Prevention 2003; 15:282-290.
163. Price MA, Zimba D, Hoffman IF, Kaydos-Daniels SC, Miller WC, Martinson F, Chilongozi D, Kip E, Msowoya E, Hobbs MM, Kazembe PN, Cohen MS. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: A randomized clinical trial. Sex. Transm. Dis. 2003; 30:516-522.
164. Balu RB, Savitz DA, Ananth CV, Hartmann KE, Miller WC, Thorp JM, Heine RP. Bacterial vaginosis, vaginal fluid neutrophil defensins and preterm birth. Obstetrics & Gynecology 2003; 101: 862-868.
165. Zenilman JM, Miller WC, Gaydos C, Rogers SM, Turner CF. LCR testing for gonorrhea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value. Sex Transm Infections 2003; 79:94-97.
166. †11Kaydos-Daniels SC, Miller WC, Hoffman IF, Banda T, Dzinyemba W, Martinson F, Cohen MS, Hobbs MM. Validation of a urine-based PCR-ELISA for use in clinical research settings to detect Trichomonas vaginalis in men. Journal of Clinical Microbiology 2003; 41:318-323. PMC149613
167. †10Sachdev M, Miller WC, Ryan T, Jollis JG. Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies. American Heart Journal 2002; 144:1065-73.
168. Balu RB, Savitz DS, Ananth CV, Hartmann KE, Miller WC, Thorp JM, Heine P. Bacterial vaginosis and vaginal fluid defensins during pregnancy. American Journal of Obstetrics and Gynecology 2002; 187:1267-1271.
169. Bodnar LM, Siega-Riz AM, Miller WC, Cogswell ME, McDonald T. Who should be screened for postpartum anemia? An evaluation of current recommendations. American Journal of Epidemiology 2002; 156:903-912.
170. Rogers SM, Miller HG, Miller WC, Zenilman JM, Turner CF. NAAT-identified and self-reported gonorrhea and chlamydial infections: Different at-risk population subgroups? Sexually Transmitted Diseases 2002; 29:588-596.
171. Bailit JL, Garrett JM, Miller WC, McMahon MJ, Cefalo RC. Hospital primary cesarean delivery rates and the risk of poor neonatal outcomes. American Journal of Obstetrics and Gynecology 2002; 187:721-7.
172. †9Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Annals of Internal Medicine 2002; 137:598-602.
173. †8Benjamin DK Jr, Miller WC, Bayliff S, Martel L, Alexander KA, Martin P. 510 Pediatric bone marrow transplants: infections diagnosed in the first year after transplant. Pediatric Infectious Diseases Journal 2002; 21:227-233.
174. Turner CF, Rogers SM, Miller HG, Miller WC, Gribble JN, Chromy JR, Leone PA, Cooley PC, Quinn TC, Zenilman J. Untreated gonococcal and chlamydial infections in a probability sample of Baltimore adults. JAMA 2002; 287:726-733.
17 CURRICULUM VITAE - William C. Miller
175. Kaydos SC, Swygard H, Wise SL, Seña AC, Leone PA, Miller WC, Cohen MS, Hobbs MM. Development and validation of a PCR-based enzyme linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. Journal of Clinical Microbiology 2002; 40: 89-95. PMC120133
176. Anderson JE, Leone PA, Miller WC, Chen CJ, Hobbs MM, Sparling PF. Selection for expression of the gonococcal hemoglobin receptor during menses. Journal of Infectious Diseases 2001; 184: 1621-1623.
177. Best D, Ford CA, Miller WC. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in pediatric private practice. Pediatrics 2001; 108: e103 (5 pages).
178. Behets FM-TF, Miller WC, Cohen MS. Syndromic treatment of gonococcal and chlamydial infections in women seeking primary care for the genital discharge syndrome: decision-making. Bulletin of the World Health Organization 2001; 79:1070-1075. PMC2566701
179. †7Benjamin DK Jr, Miller WC, Fiscus SA, Benjamin DK, Morse M, Valentine M, McKinney RE. Rational testing of the HIV exposed infant. Pediatrics 2001; 108:e3 (5 pages).
180. Ford CA, Best D, Miller WC. Confidentiality and adolescents' willingness to consent to sexually transmitted disease testing. Archives of Pediatrics and Adolescent Medicine 2001; 155:1072-3.
181. Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ Jr, Hicks CB. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001; 15:837-45.
182. †6Benjamin DK Jr, Miller W, Garges H, Benjamin DK, McKinney RE Jr, Cotten M, Fisher RG, and Alexander K. Bacteremia, central catheters and neonates: when to pull the line. Pediatrics 2001; 107:1272-6.
183. †5Ingram DM, Miller WC, Schoenbach VJ, Everett VD, Ingram DL. Selective screening criteria for gonorrhea and chlamydial infection in young children being evaluated for sexual abuse. Pediatrics 2001; 107:E73 (7 pages).
184. Bersoff-Matcha SJ, Miller WC, Aberg J, van der Horst C, Hamrick HJ Jr, Powderly WG, Mundy LM. Sex differences in nevirapine rash. Clinical Infectious Diseases 2001; 32:124-129.
185. †4Hoyo C, Miller WC, Newman B, Millikan R, Morris D, Suchindran C, Fortney J. Selective screening for cervical neoplasia: an approach for resource poor settings. International Journal of Epidemiology 2000; 29: 807-812.
186. †3Moore SG, Miller WC, Fox KK, Hoffman IF, Owen-O'Dowd J, McPherson JT, Schmitz JL, Leone PA. Clinical utility of measuring white blood cells on vaginal wet mount and endocervical gram stain for the prediction of chlamydial and gonococcal infections. Sexually Transmitted Diseases 2000; 27: 530-538.
187. †2Hartmann KE, Barrett KE, Reid VC, McMahon MJ, Miller WC. The clinical importance of white blood cell count after cesarean delivery. American Journal of Obstetrics and Gynecology 2000; 96: 295-300.
188. †1Seña AC, Miller WC, Hoffman IF, Chakraborty H, Cohen MS, Jenkins P, McKee KT. Trends of gonorrhea and chlamydial infections during 1985-96 among active duty soldiers at a United States Army installation. Clinical Infectious Diseases 2000; 30: 742-748.
18 CURRICULUM VITAE - William C. Miller
189. Miller WC, Hoffman IF, Owen-O’Dowd J, McPherson JT, Schmitz JL, Privette A, Leone PA. Selective screening for chlamydial infection: which criteria to use? American Journal of Preventive Medicine 2000; 18: 115-122.
190. Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Costello Daly C, Chakraborty H, Cohen MS, Hoffman IF. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sexually Transmitted Diseases 1999; 26: 381-387.
191. Pilcher CD, Miller WC, Beatty ZA, Nickischer D, Eron J. Detectable HIV-1 RNA at levels below quantifiable limits by Amplicor HIV-1 Monitor is associated with virologic relapse on antiretroviral therapy. AIDS 1999; 13: 1337-1342.
192. Morrison CS, Sekadde-Kigondu C, Miller WC, Weiner D, Sinei SK. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates. Contraception 1999; 59: 97-106.
193. Miller WC, Shao J, Weaver DJ, Shimokura GH, Paul D, Lallinger GJ, Seroprevalence of viral hepatitis in Tanzanian adults. Tropical Medicine & International Health 1998; 3: 757-763.
194. Miller WC. Screening for chlamydial infection: A model program based on prevalence. Sexually Transmitted Diseases 1998; 25: 201-210.
195. Miller WC. Discrepant analysis: when two wrongs don’t make a right. Journal of Clinical Epidemiology 1998; 51: 219-231.
196. Miller WC, Thielman NM, Swai N, Cegielski JP, Shao J, Ting D, Mlalasi J, Manyenga D, Lallinger GJ. Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996; 12: 303- 308.
197. Miller WC, Corey GR, Lallinger GJ, Durack DT, International health and internal medicine residency training: The Duke University experience. American Journal of Medicine 1995; 99: 291-297.
198. Miller WC, Thielman NM, Swai N, Cegielski JP, Shao J, Manyenga D, Mlalasi J, Lallinger GJ, Diagnosis and screening of HIV/AIDS using clinical criteria in Tanzanian adults. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995; 9: 408-414.
199. Naslund PK, Miller WC, Granger DJ, Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infection and Immunity 1995; 63: 1298-1304. PMC173150
200. Miller WC, Perkins MD, Richardson WJ, Sexton DJ, Mycobacterium xenopi causing Pott's disease. Clinical Infectious Diseases 1994; 19: 1024-1028.
201. Hoebel BG, Hernandez L, Monaco AP, Miller WC, Amphetamine-induced overeating and overweight in rats. Life Sciences 1981; 28:77-82.
Other Peer-Reviewed Articles including Review Articles
1. Rosenberg NE, Pettifor AE, Miller WC. The awareness framework: A novel approach for understanding HIV testing and disclosure in HIV-discordant dyads. J Antivir Antiretrovir. 2013 ; 5:008-011. PMC4196702
19 CURRICULUM VITAE - William C. Miller
2. Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS.The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr. 2013;63 Suppl 2:S187-99
3. Miller WC, Rosenberg NE, Rutstein SE, Powers KA. The role of acute and early HIV infection in the sexual transmission of HIV. Current Opinion in HIV and AIDS. 2010; 5:277-82. PMC3130067
4. Baecher-Lind LE, Miller WC, Wilcox AJ. Infectious disease and reproductive health: a review. Obstet Gynecol Surv. 2010;65:53-65.
5. Miller WC, Zenilman JM. Epidemiology of chlamydial infection, gonorrhea, and trichomoniasis in the United States-2005. Infect Dis Clin North Am. 2005;19:281-296. (Invited Review).
6. Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, Brody S, Miller WC. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ). 2005 Feb;(119):1-8.
7. Miller WC, Durack DT. Fever of unknown origin in HIV-infected adults. Hospital Medicine 1996; 32: 27-34.
8. Miller WC, Durack DT. Fever of unknown origin: A rational approach to diagnosis in the 1990's. Hospital Medicine 1994; 30: 49-56.
Invited Commentaries and Editorials
1. Miller WC. What STD means to me. Sex Transm Dis. 2015;42:4.
2. Powers KA, Kretzschmar ME, Miller WC, Cohen MS. Impact of early-stage HIV transmission on treatment as prevention. Proc Natl Acad Sci U S A. 2014 Nov 3. [Epub ahead of print]
3. Miller WC, Nguyen N. Relative or absolute? A significant intervention for chlamydia screening with small absolute benefit. Sex Transm Infect. 2014; 90:172-3.
4. Gay C, Adimora A, Miller W, Cohen MS. Surveillance of HIV in the United States and England, Wales, and Northern Ireland: What have we learned and what do we do about it? Sex Transm Dis. 2014;41:266-7.
5. Miller WC, Lesko CR, Powers KA. The HIV care cascade: Simple concept, complex realization. Sex Transm Dis. 2014;41:41-2.
6. Miller WC, Siripong N. Estimates of sexually transmitted infection prevalence and incidence in the United States: Time to embrace uncertainty. Sex Transm Dis. 2013; 40:194-196.
7. Miller WC. Reference test bias in diagnostic test evaluation: A problem for epidemiologists, too. Epidemiology 2012; 23:83-5.
8. Miller WC, Ko EM. Chlamydial infection and risk of cervical neoplasia: the challenge is in the study design. Sex Transm Infect. 2011; 87:366-7. [Epub ahead of print, Jun 16]
9. Miller WC, Cholera R. Comparing the prevalence of chlamydial infection across populations – What is appropriate? Sex Transm Dis. 2011;38:79-81.
10. Miller WC. Infectious Disease (in) EPIDEMIOLOGY. Epidemiology. 2010;21:593-4.
11. Miller WC. Epidemiology of chlamydial infection: Are we losing ground? Sex Transm Infect. 2008 Apr;84(2):82-6.
20 CURRICULUM VITAE - William C. Miller
12. Miller WC. Decreasing age disparities in syphilis and gonorrhea incidence rates in the United States, 1981-2005. Sex Transm Dis. 2008 Apr;35(4):398-9.
13. Miller WC. Screening for chlamydial infection: Are we doing enough? Lancet 2005; 365:456-458.
14. Schoenbach VJ, Poole C, Miller WC. Should we estimate incidence for undefined populations? American Journal of Epidemiology 2001; 153:935-937.
15. Savitz DA, Poole C, Miller WC. Reassessing the role of epidemiology in public health. American Journal of Public Health 1999; 89:1158-1161. PMC1508699
16. Cohen MS, Miller WC. Sexually transmitted diseases and HIV infection: cause, effect or both? International Journal of Infectious Diseases 1998; 3:1-4.
17. Miller WC. Can we do better than discrepant analysis for new diagnostic test evaluation? Clinical Infectious Diseases 1998; 27:1186-1193.
Letters to the Editor
1. Powers KA, Klein PW, Cholera R, Miller WC. Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'. AIDS. 2013;27:2825-6.
2. Miller WC, Hoffman IF, Latkin CA, Strathdee SA, Shoptaw S. HIV antiretroviral prophylaxis for injecting drug users. Lancet. 2013;382:853.
3. †5Rosenberg NE, Kamanga G, Phiri S, Nsona D, Pettifor A, Rutstein SE, Kamwendo D, Hoffman IF, Keating M, Brown LB, Ndalama B, Fiscus SA, Congdon S, Cohen MS, William C. Miller WC. Point-of-Care Diagnostics for Acute HIV Infection: An Important Public Health Priority. J Infect Dis 2012; doi: 10.1093/infdis/jis618
4. †4Bowman N, Goswami N, Lippincott CK, Vinikoor MJ, Miller WC. Clinical scoring for risk of resistant organisms in pneumonia: Right idea, wrong interpretation. Clin Infect Dis. 2012; 55:749- 50. (Jun 5. [Epub ahead of print])
5. Pettifor AE, Miller WC, Cohen M, Macphail C, Rees H. The Authors reply. J Adolesc Health. 2012;50:209-10.
6. Powers KA, Ghani AC, Miller WC, Pettifor AE, Cohen MS. The Authors reply. Lancet 2011; 378:1914-1915.
7. †3Turner AN, Miller WC, Padian NS, Kaufman JS, Behets FM, Chipato T, Morrison CS. Population- average models and sexual network studies are complementary approaches to study HIV risk. Int J Epidemiol. 2011; 40: 257-258. (Epub ahead of print 2010 May 10.)
8. Miller WC, Ford CA, Hobbs MM, Cohen MS, Schmitz JL, Harris K Mullan, Handcock MS, Morris M. In Reply: Prevalence of chlamydial and gonococcal infection among young adults. JAMA 2004; 292: 801-802.
9. †2Mulherin SA, Miller WC. In Response: Subgroup variation in diagnostic test evaluation. Annals of Internal Medicine 2003; 138:686-687.
10. Sarmiento OL, Ford CL, Newbern EC, Miller WC, Poole C, Kaufman JS. The importance of assessing effect modification when asserting racial differences in associations between human leukocyte antigen class II alleles and hepatitis C virus outcomes. Journal of Infectious Diseases 2002; 185:266-267.
21 CURRICULUM VITAE - William C. Miller
11. Bersoff-Matcha S, Miller W, Mundy LM. Reply: Sex differences in nevirapine rash. Clinical Infectious Diseases 2001; 33:2097-2098.
12. †1Fink KS, Miller WC. Bedside diagnostic tests for pulmonary embolism (letter). JAMA 2001; 285: 2326-2327.
13. Hadgu A, Miller W. Using a combination of reference tests to assess the accuracy of a diagnostic test. Statistics in Medicine 2001; 20: 656-658.
Abstracts
1. Rutstein S, Pettifor A, Phiri S, Kamanga G, Nsoma D, Massa C, Wiyo P, Pasquale D, Hoffman I, Tegha G, Mapanje C, Hosseinipour M, Rosenberg NE, Puruma S, Phiri M, Tembo B, Miller W. Identifying persons with acute HIV infection in urban Malawi HIV testing and sexually transmitted infection clinics: an opportunity for HIV transmission prevention. 20th International AIDS Conference; 20-25 July 2014, Melbourne, Australia. MOPE031 (poster)
2. Dukhovlinova E, Masharsky A, Verevochkin S, Toussova O, Shevchenko A, Montefiori D, Hoffman I, Miller W, Kozlov A, Swanstrom R. AHI detection among people who inject drugs in Russia reveals the HIV-1 transmission bottleneck. CROI, March 2014, Boston, MA. P-B3-224 (poster).
3. Davis NL, Miller WC, Hudgens MG, Chasela CS, Sichali DS, Kayira D, Kourtis AP, Ellington SR, Jamieson DJ, van der Horst CM. Antiretoviral adherence associated with reduced breastmilk HIV-1 Transmission: The BAN Study. CROI, March 2014, Boston, MA. P-T7-880 (poster).
4. Powers K, Ghani A, Miller W, Hoffman I, Pettifor A, Kamanga G, Martinson F, Cohen M. Modeling the effect of “risk interruption” interventions on HIV prevalence in Lilongwe, Malawi. XIX International AIDS Conference, July 2012, Washington, DC. MOPE141 (poster).
5. Powers K, Ghani A, Miller W, Hoffman I, Pettifor A, Hosseinipour M, Kamanga G, Martinson F, Cohen M. The contribution of HIV-discordant couples to HIV transmission in Lilongwe, Malawi. XIX International AIDS Conference, July 2012, Washington, DC. TUPDC0204 (Oral poster).
6. Rosenberg NE, Kamanga G, Bonongwe N, Pettifor AE, Mapanje C, Nkhata L, Rutstein SE, Hoffman I,, Martinson F, Miller WC. Social network recruitment by STI patients is a promising strategy for identifying STIs and HIV in resource-limited settings. XIX International AIDS Conference, July 2012, Washington, DC. TUPE732 (Poster).
7. Mapanje C, Rutstein S, Kamanga G, Phiri S, Nsona D, Pettifor A, Rosenberg N, Hoffman I, Miller W. More frequent sexual risk behaviors among HIV-uninfected sexually transmitted infection clinic patients compared to HIV-infected and HIV-uninfected HIV testing and counseling center patients in Lilongwe, Malawi. XIX International AIDS Conference, July 2012, Washington, DC. TUAC0202 (oral).
8. Rogers S, Turner C, Miller W, Roman A, Hobbs M, Tan S. Increased risk for T. vaginalis in an urban population of young adults. 19th ISSTDR Meeting, Quebec, Canada; July, 2011; Abstract O1- S05.04 (oral).
9. Sampson LA, Miller WC, Leone PA. Evaluation of risk-score algorithms for the detection of HIV infection and syphilis in North Carolina county jails. 19th ISSTDR Meeting, Quebec, Canada; July, 2011; Abstract P1-S6.34 (poster).
10. Powers K, Kamanga G, Mapanje C, Malava JK, Chindebvu M, Kamzati H, Martinson F, Miller W, Cohen M, Hoffman I Longitudinal trends in HIV testing and prevalence among STI clinic patients in
22 CURRICULUM VITAE - William C. Miller
Lilongwe, Malawi: 2006-2010. 19th ISSTDR Meeting, Quebec, Canada; July, 2011; Abstract P1- S6.29 (poster).
11. Kamanga G, Powers K, Mapanje C, Mkandawire N, Milonde H, Kanyamula H, Wiyo P, Martinson F, Miller W, Hoffman I. Longitudinal trends in syndromic STI diagnoses in Lilongwe, Malawi: 2006- 2010. 19th ISSTDR Meeting, Quebec, Canada; July, 2011; Abstract P1-S1.24 (poster).
12. Gesink D, Sullivan A, Norwood T, Serre M, Miller W. Does core theory apply in rural environments? 19th ISSTDR Meeting, Quebec, Canada; July, 2011; Abstract P1-S4.14 (poster).
13. Miller WC, Kamanga G, Phiri S, Nsona D, Rosenberg N, Rutstein S, Kumwendo D, Hoffman I, Cohen M, Pettifor A. Poor performance of Determine HIV 1/2 Ag/Ab Combo Assay for the detection of acute HIV infection in Lilongwe, Malawi. CROI, Boston, MA; March 2011, Abstract # 654 (poster).
14. Powers K, Ghani A, Miller W, Hoffman I, Pettifor A, Kamanga G, Martinson F, Cohen M. The contribution of early HIV infection to HIV spread in Lilongwe, Malawi: Implications for transmission prevention strategies. XVIII International AIDS Conference, Vienna, Austria, July 18-23, 2010, Abstract #FRLBC105.
15. Eggleston E, Rogers S, Turner CF, Roman A, Tan S, Miller W, Hobbs M, Erbelding E, Ganapathi L. Sexually transmitted infections and sexual risk behaviors: Comparing teenagers and adults in a probability sample of residents of Baltimore, MD, USA. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.20 (poster).
16. Powers KA, Miller WC, Hoffman IF, Hosseinipour M, Ghani AC, Chilongozi D, Martinson FE, Cohen MS. Partnership lengths, concurrency, and gaps between consecutive partnerships in a Malawian STI Clinic. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#OS-1.8.01 (oral).
17. Weiss H, Phiri S, Paz Bailey G. Gresenguet G, LeGoff J, Pepin J, Lewis D, Belec L, Hoffman I, Miller WC, Mayaud P. Episodic therapy for genital herpes in sub-saharan Africa: A pooled analysis from three randomised controlled trials. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#OS-2.2.04 (oral).
18. Tarman JS, Fitch MK, Gesink Law DC, Sullivan A, Norwood T, Hampton KH, Doherty IA, Allshouse WB, Leone PA, Miller WC, Serre ML. Modeling a syphilis outbreak in North Carolina using the Bmegui tool of modern space/time geostatistics.18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#OS-2.8.04 (oral).
19. Doherty IA, Muth SQ, Adimora AA, Gesink Law DC, Fitch MK, Hampton KH, Allshouse WB, Serre ML, Leone PA, Miller WC. Where was the outbreak? Use of number of cases, incidence rates, and sexual networks to assess a syphilis outbreak in North Carolina. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract #OS-2.8.05 (oral)
20. McCoy SI, Miller WC, Eron JJ, Strauss RP. Suicidal ideation and attempted suicide after HIV diagnosis: Implications for referral and initiation of care. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-2.117 (poster).
21. Sullivan A, Gesink Law D, Zhou L, Brown P, fitch M, Serre ML, Miller WC. Do social determinants influence the spatiotemporal pattern of gonorrhea in North Carolina, USA. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.1 (poster).
22. Turner CF, Rogers SM, Eggleston E, Roman AM, Tan S, Miller WC, Hobbs M, Erbelding E, Ganapathi L. Prevalence of symptoms among persons with diagnosed and undiagnosed
23 CURRICULUM VITAE - William C. Miller
chlamydial (Ct) and trichomonas baginalis (Tv) infections. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.15 (poster).
23. Hoffman I, Kamanga G, Mapanje C, Brown L, Powers K, Krysiak RG, Hobbs MM, Chen C, Chilongozi DA, Hosseinipour M, Miller WC, Cohen MS, Martinson FE, Phiri S. The etiology of GUD in Malawi : 1992-20018th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.181(poster).
24. Hobbs M, Rogers SM, Turner CF, Miller WC, Rich KD, Schmitz JL, Erbelding EJ, Eggleston E. Vanishing undiagnosed gonococcal infectiouns in an urban American community. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.5 (poster).
25. Doherty IA, Muth SQ, Fitch MK, Law DCG, Allshouse WB, Serre ML, Leone PA, Miller WC. Geographical trends of compactness and directional bias of sexual networks in North Carolina during an outbreak. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009 Abstract#P- 3.50 (poster).
26. Hampton KH, Fitch MK, Allsbouse WB, Law DCG, Doherty IA, Leone PA, Serre ML, Miller WC. Mapping individual STD case data: Geomasking events to protect patient privacy. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.77 (poster).
27. Allshouse WB, Fitch MK, Hampton KH, Law DCG, Doherty IA, Leone PA, Serre ML, Miller WC. An evaluation of privacy protection when geomasking STI data. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-3.78 (poster).
28. Gesink Law D, Norwood T, Sullivan A, Fitch M, Serre ML, Miller WC. Core areas in rural environments. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P- 3.80 (poster).
29. Doherty IA, Muth SQ, Adimora AA, Fitch MK, Tarman JS, Hampton KH, Gesink Law DC, Allshouse WB, Serre ML, Leone PA, Miller WC. Sexual mixing patterns by geography, race/ ethnicity, age, and sexual activity during a heterosexual syphilis outbreak in North Carolina. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-4.25 (poster).
30. Rogers S, Turner CF, Eggleston E, Roman AM, Miller WC, Hobbs MM, Tan S, Erbelding E. Trichomonas vaginalis infection in a probability sample of Baltimore, USA adolescents and young adults. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P- 4.55 (poster).
31. Rogers S, Turner CF, Miller WC, Eggleston E, Erbelding E. Chlamydial infections among young adults in Baltimore, MD, USA: Trends across the last decade. 18th ISSTDR Meeting, London, United Kingdom; June – July, 2009. Abstract#P-4.74 (poster).
32. Hampton KH, Fitch MK, Allshouse WB, Gesink Law DC, Doherty IA, Leone PA, Serre ML, Miller WC. Protecting patient confidentiality when mapping health data: An analysis of geomasking algorithms. ISEA-ISEA 2008 Joint Annual Conference - Exposure and Health in a Global Environment, Pasadena, CA. October, 2008. Abstract #1561, poster.
33. Allshouse WB, Hampton KH, Leone PA, Miller WC, Serre ML. Methods for space/time mapping of HIV incidence rates in North Carolina. ISEA-ISEA 2008 Joint Annual Conference - Exposure and Health in a Global Environment, Pasadena, CA. October, 2008. Abstract # 679, poster.
34. Fitch MK, Allshouse WB, Hampton KH, Gesink Law DC, Doherty IA, Leone PA, Serre ML, Miller WC. a comparison of estimated versus actual K-anonymity when geomasking sensitive health data.
24 CURRICULUM VITAE - William C. Miller
ISEA-ISEA 2008 Joint Annual Conference - Exposure and Health in a Global Environment, Pasadena, CA. October, 2008. Abstract #1075, oral.
35. Robinson J, Akatova N, Denisheva G, Rakhmanova A, Yakovlev A, Stepanova E, Miller W, Kissin D, Jamieson D, Hillis S. Home visits: Facilitating entry into care and treatment programs for HIV- infected women and HIV-exposed infants identified during PMTCT services St. Petersburg, Russia, 2005-2007. XVII International AIDS Conference, Mexico City, Mexico, August, 2008.
36. Hillis S, Kuklina E, Akatova N, Kissin D, Vinogradova A, Rakhmanova A, Stepanova E, Jamieson D, Robinson J, Miller W. Epidemiology of perinatal HIV transmission, St. Petersburg, Russia. XVII International AIDS Conference, Mexico City, Mexico, August, 2008.
37. Fitch, M, Allshouse W, Serre ML, Hampton K, Gesink Law D, Leone P, W. Miller. Geomasking algorithms to protect confidentiality of sexually transmitted infections in spatial epidemiology, American Public Health 135th Annual Meeting & Exposition, Roundtable Presentation, Washington, DC, USA, November 2007 (oral).
38. Al-Tayyib AA, Miller WC, Rogers SM, Gesink Law DC, Ford CA, Leone PA, Rothman RE. Healthcare access and follow-up of chlamydial and gonococcal infections identified in an emergency department setting. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract# O-016 (oral).
39. Norris Turner A, Morrison CS, Padian NS, Kaufman JS, Salata RA, Chipato T, Celentano DD, Rugpao S, Mmiro FA, Miller WC. Male circumcision and women’s risk of incident chlamydial, gonococcal and trichomonal infections. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#O-020 (oral).
40. Norris Turner A, Miller WC, Padian NS, Kaufman JS, Behets FM, Chipato T, Mmiro FA, Salata RA, Morrison CS. Unprotected sex in HIV-infected women in Uganda and Zimbabwe: short- and long- term comparisons with pre-diagnosis behavior. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#O-117 (oral).
41. Khan MR, Miller WC. Adolescents and young adults Depression and STI among young adults in the US, with a focus on youth heading towards incarceration. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#P-012 (poster).
42. Hobbs MM, Rich KD, Reed J, Kahn J, Mortensen J, Miller WC, Huppert J. Comparison of transcription-mediated amplification, rapid antigen test, culture and wet mount for detection of Trichomonas vaginalis in female adolescents. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#P-137 (poster).
43. Khan MR, Adimora AA, Schoenbach VJ, Miller WC. Incarceration and risky sexual partnership among African Americans in the southern United States. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#P-362 (poster).
44. Pettifor AE, Delany S, Kleinschmidt I, Miller WC, Rees HV. Hormonal contraception use and risk of STI infection amongst South African women. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#P-576 (poster).
45. Atashili J, Miller WC, Swygard H, Leone PA, Sena AC. Male circumcision and other male partner (non)correlates of bacterial vaginosis in a group of STD clinic attendees in the United States. 17th ISSTDR Meeting - 10th IUSTI World Congress, Seattle, WA; July-August 2007. Abstract#P-646 (poster).
25 CURRICULUM VITAE - William C. Miller
46. Krobot KJ, Kaufman JS, Christensen DB, Preisser JS, Miller WC, Ibrahim MA. Health services research into the German statutory and private healthcare system. German Medical Science; 2005. Doc 05gmds113. http://www.egms.de/en/meetings/gmds2005/05gmds014.shtml
47. Krobot KJ, Kaufman JS, Christensen DB, Preisser JS, Miller WC, Ibrahim MA. Assessing access to medical care through an epidemiological extension of econometric hurdle models. German Medical Science; 2005. Doc 05gmds111 http://www.egms.de/en/meetings/gmds2005/05gmds013.shtml
48. Sampson LA, Leone PA, Miller WC, Hedenquist RB. Risk factors for syphilis and HIV in North Carolina jail detainees. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # WP-076 (poster.)
49. Al-Tayyib AA, Villarroel MA, Ellen JM, Miller WC, Rogers SM. Follow-up of chlamydial and gonococcal infections identified in an emergency department setting. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # TP-138 (poster.)
50. Al-Tayyib AA, Miller WC, Rothman R, Villarroel MA, Rogers SM. Evaluation of risk score algorithms for detection of undiagnosed chlamydial and gonococcal infections in an emergency department setting. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # TP-128 (poster.)
51. Ford CA, Jaccard J, Millstein SG, Bardsley PE, Miller WC. STI-testing behaviors in the U.S. National Longitudinal Study of Adolescent Health: Do young adults want to know if they are infected with chlamydia or gonorrhea? 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # TP-088 (poster.)
52. Rogers SM, Miller WC, Ellen JE, Zenilman J, Rothman R, Turner CF, Al-Tayyib AA, Villarroel MA. Transmissibility of Chlamydia trachomatis infections detected using nucleic acid amplification tests. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # TP-070 (poster.)
53. Miller WC. Diagnosis: The Promise and the Pitfalls of Chlamydia Screening with Nucleic Acid Amplification Tests; Current Controversies in Chlamydia Screening: What Works and at what Cost. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005 (invited oral presentation).
54. Hobbs M, Lapple DM, Lawing LF, Schwebke JR, Cohen MS, Swygard H, Atashili J, Leone PA, Miller WC, Seña AC. Performance of culture and PCR for detection of Trichomonas vaginalis in the male partners of infected women in the U.S. International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # TO-103 (oral.)
55. Bernstein KT, Law DCG, Serre ML, Schumacher CM, Leone PA, Miller WC, Zenilman JM, Rompalo AM. Space-time modeling of an early syphilis outbreak. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # MP-192 (poster.)
56. Hoffman IF, Pilcher CD, Galvin S, Mapanje C, Martinson FEA, Chilongozi DA, Powers K, Miller WC, Fiscus SA, Cohen MS. Associations among STDs, acute HIV infection, and HIV shedding, Lilongwe, Malawi. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005, Abstract # MO-003 (oral presentation.)
26 CURRICULUM VITAE - William C. Miller
57. Ford CA, Jaccard J, Millstein SG, Bardsley PE, Miller WC. Result-seeking behavior in Wave III Add Health STI: Do young adults want to know if they are infected with chlamydia or gonorrhea? Journal of Adolescent Health. 2005; 36(2):97-98.
58. Ford CA, Miller WC, Pence B, Resnick MD, Bearinger LH, Pettingell S, Cohen M. Do family and school factors protect adolescents from sexually transmitted infections in young adulthood? Pediatric Research. 2004; 55(4) Part 2: 2A..
59. Ford CA, Jaccard J, Millstein SG, Miller WC. Who refuses to provide a urine specimen for Chlamydia trachomatis and Neisseria gonorrhoeae testing? Journal of Adolescent Health. 2004; 34(2):144; and Pediatric Research. 2004: 55(4) Part 2: 9A.
60. Iritani B, Hallfors D, Ford CA, Halpern CT, Miller WC. Assay results vs. self-reported chlamydial infections: Does measurement discrepancy vary by level of risk behavior? Abstract #A10C 2004 National STD Prevention Conference; Philadelphia, PA, March 8-11, 2004.
61. Law DCG, Serre ML, Christakos G, Leone P, Miller WC. Analyzing and mapping the spatial distribution of sexually transmitted diseases for public health intervention. Abstract # 0321 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
62. Smurzynski M, Miller WC, Fox K, Barnes R, Irwin KL, Leone P. Herpes simplex type 2 infection in persons seeking HIV testing in North Carolina. Abstract # 0452 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
63. Smurzynski M, Miller WC, Fox K, Barnes R, Irwin KL, Leone P. STD infection in HIV-infected patients in continuing care in North Carolina: A cohort study. Abstract # 0457 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
64. Seña AC, Miller WC, Schwebke JR, Leone P, Swygard H, Taylor DJ, Hobbs MM, Cohen M. Trichomonas vaginalis infection in the sexual partners of infected women. Abstract # 0484 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
65. Law DCG, Serre ML, Leone P, Miller WC. Spatiotemporal changes in chlamydial infection patterns and persistence of the spatial core. Abstract # 0508 ISSTDR Congress; Ottawa, Canada, July 27- 30, 2003.
66. Seña AC, Miller WC, Joanis CL, Taylor DJ, Leone P, Schwebke JR, Cohen M. Acceptability of microbicides to prevent sexually transmitted infections. Abstract # 0512 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
67. Miller WC, Morris M, Handcock MS, Hobbs MM, Ford CA, Schmitz JL, Cohen M, Harris KM, Udry JR. Prevalence of trichomoniasis in the U.S.: Results from a representative national sample of young adults. Abstract # 0527 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
68. Patnaik P, Weir S, Das B, Miller WC, Boerma TJ. Priorities for local AIDS control efforts (PLACE) method identifies new locations that warrant increased AIDS prevention in Bhubaneswar, India. Abstract # 0528 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
69. Miller WC, Morris M, Handcock MS, Ford CA, Schmitz JL, Hobbs MM, Cohen M, Harris KM, Udry JR. Prevalence of gonorrhea in the U.S.: Results from a representative national sample of young adults. Abstract # 0536 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
70. Miller WC, Morris M, Handcock MS, Ford CA, Schmitz JL, Hobbs MM, Cohen M, Harris KM, Udry JR. Prevalence of chlamydial infection in the U.S.: Results from a representative national sample of young adults. Abstract # 0542 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
27 CURRICULUM VITAE - William C. Miller
71. Edozien AO, Seña AC, Miller WC. Chlamydial infection in young males attending a public STD clinic. Abstract # 0661 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
72. Morris M, Handcock MS, Miller WC, Ford CA, Schmitz JL, Hobbs MM, Cohen M, Harris KM, Udry JR. Prevalence of HIV infection in the U.S.: Results from a representative national sample of young adults. Abstract # 0591 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
73. Swygard H, Miller WC, Kaydos-Daniels N, Cohen M, Leone P, Hobbs MM, Seña AC. Targeted screening for Trichomonas vaginalis using a two-step detction method in women presenting for STD evaluation. Abstract # 0558 ISSTDR Congress; Ottawa, Canada, July 27-30, 2003.
74. Krobot KJ, Kaufman JS, Christensen DB, Miller WC, Preisser JS, Ibrahim MA. Athree-dimensional person-time-related hurdle model to characterize the influence of type of health insurance on the use of sumatriptan for acute therapy of migraine in the second through fourth year of the drug macrobudget in Germany. Society for Epidemiological Research; Atlanta, GA, June 11-14, American Journal of Epidemiology, 2003; 157(11): S86.
75. Krobot KJ, Miller WC, Kaufman JS, Christensen DB, Preisser JS, Ibrahim MA. Access to healthcare using risk advancement periods: The use of sumatriptan for migraine therapy by type of health insurance in Germany. Society for Epidemiological Research; Atlanta, GA, June 11-14, American Journal of Epidemiology, 2003; 157(11): S86.
76. Hightow LB, Miller W, Leone PA, Wohl DA, Smurzynski M, Kaplan A. Failure to return for HIV posttest counseling in an STD clinic population. Abstract# 918, 10th Conference on Retroviruses and Opportunistic Infections; Boston, MA, Feb 11-14, 2003.
77. Krobot KJ, Miller WC, Kaufman JS, Christensen DB, Preisser JS, Ibrahim MA. Der Zugang zum gesundheitlichen Nutzen durch Arzneimittelinnovation in Deutschland: Um wie viele Jahre ist er verzögert ? Informatik, Biometrie und Epidemiologie in Medizin und Biologie 2002; 33(2-3): 417. 10th Annual Meeting of the German Epidemiology Working Group (DAE), Berlin, September 9-11, 2002.
78. Kublin JG, Miller WC, Jere CS, Chisi JE, Hoffman IF, Mbewe B, Pendame R. Identifying a possible HIV vaccine testing site. Abstract# TuPeC4837, XIV International AIDS Conference; Barcelona, Spain; July 7-12, 2002
79. Patnaik P, Weir SS, Das B, Miller WC, Boerma JT. Assessment of the priorities forLocal AIDS control efforts(PLACE) method for facilitation of AIDS prevention in India. Abstract# TuPeD5037, XIV International AIDS Conference; Barcelona, Spain; July 7-12, 2002
80. Min SS, Miller WC, Leone PA. A questionnaire study to determine Emergency Department policy for HIV/STD post-exposure prophylaxis of sexual assault victims in the State of North Carolina. Abstract# TuPeF5381, XIV International AIDS Conference; Barcelona, Spain; July 7-12, 2002
81. Kublin JG, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Taylor TE, Molyneux ME. Malaria infection elevates HIV-1 viral load. Abstract# WeOrC1375, XIV International AIDS Conference; Barcelona, Spain; July 7-12, 2002
82. Menezes P, Napravnik S, Miller WC, Eron JJ Jr.-Factors associated with normal CD4:CD8 ratios in HIV infected persons. Abstract# WePeC6232, XIV International AIDS Conference; Barcelona, Spain; July 7-12, 2002
28 CURRICULUM VITAE - William C. Miller
83. Sarmiento OL, Ford CA, Miller WC. Factors associated with having an annual routine medical exam among Latino adolescents of Mexican, Cuban, Puerto Rican, Central/South American and Dominican Republic origin. J Adolesc Health. 2002;30(2):106.
84. Sarmiento OL, Ford CA, Miller WC. Factors associated with receiving an annual routine medical exam among Latino adolescents. Abstract 2002 Pediatric Academic Societies' Meeting; Baltimore, MD; 2002.
85. Smurzynski M, Moran T, Nguyen TQ, Cohen TH, Irwin K, Fox KK, Barnes R, Leone PA, Miller WC. STD screening and diagnostic testing policies among primary care practices in Wake County, North Carolina. Abstract #P100 (p.A.139). 2002 National STD Prevention Conference; San Diego, CA; March 4-7, 2002
86. Smurzynski M, Miller WC, Moran T, Irwin K, Fox KK, Barnes R, Leone PA. Current STD infection and HIV testing: A case-control study. Abstract #P148(p.A.172). 2002 National STD Prevention Conference; San Diego, CA; March 4-7, 2002
87. Sarmiento OL, Miller WC, Ford CA. The relationship between number of sexual partners and receiving an annual medical exam among Latino adolescents: Modifying role of acculturation. Abstract #P38 (p.A.98) 2002 National STD Prevention Conference; San Diego, CA; March 4-7, 2002
88. Price MA, Zimba D, Hoffman IF, Kazembe PN, Kaydos SC, Agabu A, Mohango J, Miller WC, Cohen MS. Adding metronidazole to the standard syndromic treatment for urethritis does not improve cure rates in Malawi. International Journal of STD & AIDS 2001; 12 (Suppl 2): 46. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
89. Patnaik P, Weir SS, Das B, Miller WC, Boerma JT. Assessment of high transmission area method for HIV/STD prevention in India. International Journal of STD & AIDS 2001; 12 (Suppl 2): 79. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
90. Leone PA, Tilson EC, Sanchez V, Ford CL, Smurzynski M, Miller WC. Barriers to asymptomatic screening and other STD services for young adults and adolescents in a southeastern community: a qualitative analysis. International Journal of STD & AIDS 2001; 12 (Suppl 2): 83. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
91. Hobbs MM, Martinson F, Kaydos SC, Wise SL, Banda T, Namakhwa DH, Malanda J, Miller WC, Hoffman I, Cohen MS. Validation of a new urine-based PCR-ELISA assay for the detection of Trichomonas vaginalis infection in men. International Journal of STD & AIDS 2001; 12 (Suppl 2): 131. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
92. Miller WC, Law DG, Leone PA. Monitoring spatial changes in syphilis rates using geostatistics. International Journal of STD & AIDS 2001; 12 (Suppl 2): 135. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
93. Patnaik P, Miller WC. Association of access to condoms and STD prevalence among married men in Uttar Pradesh, India. International Journal of STD & AIDS 2001; 12 (Suppl 2): 190. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
94. Sarmiento OL, Weigle K, Alexander J, Weber DJ, Miller WC. Performance of polymerase chain reaction for the diagnosis of paucibacillary pulmonary tuberculosis: A meta-analysis. Abstract #795. 2001 Congress of Epidemiology; Toronto, Canada; June 2001.
29 CURRICULUM VITAE - William C. Miller
95. Barnes R, Cohen D, Farley T, Nwokolo E, Rompalo A, Fox K, Leone P, Miller W, Irwin K, Kamb M. Assessment of STD control interventions for HIV prevention in the US: preliminary data from New Orleans, Baltimore, and Raleigh, USA. International Journal of STD & AIDS 2001; 12 (Suppl 2): 31. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
96. Kaydos SC, Hobbs MM, Price MA, Dzinyemba W, Phakati S, Kazembe P, Hoffman I, Miller WC, Cohen MS. Sites of Trichomonas vaginalis infection in the genitourinary tract of Malawian men. International Journal of STD & AIDS 2001; 12 (Suppl 2): 39. International Congress of Sexually Transmitted Infections; Berlin, Germany; June 2001.
97. Tilson EC, Sanchez V, Ford CL, Smurzynski M, Leone PA, Fox KK, Miller WC. Barriers to asymptomatic screening and other STD services for young people in a southeastern community. Abstract # PS24. Preventive Medicine 2001: Science and Systems of Health; Miami, FL; February 2001.
98. Irwin KL, Kamb M, Farley T, Cohen D, Rompalo A, Rose D, Dunning R, Miller W, Leone P, Fox K, Foust E. Does improved sexually transmitted disease control prevent HIV transmission in the U.S.? A preliminary quantitative assessment using the Piot-Fransen model of STD management. American Statistical Association's International Conference on Health Policy Research: Methodological Issues in Health Services and Outcomes Research; December 2000; Santa Monica, CA.
99. Ford CL, Tilson EC, Smurzynski M, Fox KK, Leone PA, Miller WC. Improving access to STD services in a North Carolina city: Lessons learned from the outreach process. Abstract P76. 2000 National STD Prevention Conference; Milwaukee, WI; December 2000.
100. Law DG, Miller WC, Christakos G, Blue K, Smurzynski M, Fox KK, Leone PA. Deriving a surface of chlamydial infection rates using geostatistics. Session C4. 2000 National STD Prevention Conference; Milwaukee, WI; December 2000.
101. Sachdev M, Miller WC, Jollis JG. What is the true prevalence of fenfluramine associated valve regurgitation?: A meta-analysis. Abstract #109785. American Heart Association; New Orleans, LA; November 2000.
102. Benjamin DK Jr, Miller WC, Garges H, Benjamin DK, McKinney RE Jr, Cotten M, Fisher RG, and Alexander K. Bacteremia, central catheters and neonates: when to pull the line. Infectious Diseases Society of America; New Orleans, LA; September 2000.
103. Law DG, Miller WC, Hoffman IF, Owen-O'Dowd J, Leone PA. Does community variation account for racial differences in the prevalence of chlamydial infection? Abstract # 27. STIs at the Millennium Conference; Baltimore, MD; May 2000.
104. Newbern EC, Miller WC. Racial differences in sexually transmitted disease risks in the Longitudinal Study of Adolescent Health (Add Health). Abstract # 39. STIs at the Millennium Conference; Baltimore, MD; May 2000.
105. Miller WC, Hoffman IF, Patnaik P, Owen-O'Dowd J, Leone PA. Race/ethnicity and selective screening for chlamydial infection. Abstract # 94. STIs at the Millennium Conference; Baltimore, MD; May 2000.
106. Best D, Ford CA, Miller WC. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in pediatric primary care settings with implications for screening practices. Pediatric Academic Societies & American Academy of Pediatrics Joint Meeting, 2000.
30 CURRICULUM VITAE - William C. Miller
107. Ford CA, Best DB, Miller WC. Confidentiality and adolescents' willingness to consent to urine- based STD Testing in private practice settings. Journal of Adolescent Health. 2000; 26(2): 129. Society for Adolescent Medicine 2000 Annual Meeting, Arlington, VA; March 2000.
108. Best DB, Ford CA, Miller WC. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in adolescents and young adults in primary care pediatric settings. Journal of Adolescent Health. 2000; 26(2): 140. Society for Adolescent Medicine 2000 Annual Meeting, Arlington, VA; March 2000.
109. Kamb M, Irwin K, Cohen D, Farley T, Rompalo A, Dunning R, Miller W, Leone P, Fox K. Assessing feasibility of STD control interventions for HIV prevention in the U.S. Abstract #467. 7th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA; January 2000.
110. Irwin KL, Kamb M, Farley T, Cohen D, Rompalo A, Rose D, Dunning R, Miller W, Leone P, Fox K, Foust E. Update on feasibility projects for STD control as an HIV prevention strategy in the U.S. First National HIV Prevention Meeting; Atlanta, GA; August 1999.
111. Swygard H, Seña A, Krysiak RG, Hobbs MM, Miller WC, Leone PA, Cohen MS. Assessment of a urine based polymerase chain reaction assay for the detection of Trichomonas vaginalis in women. Abstract #20. 13th Meeting of the International Society for Sexually Transmitted Disease Research; Denver, CO; July 1999.
112. Smurzynski M, Miller WC. Gender differences: self-reported previously diagnosed sexually transmitted disease and human immunodeficiency virus positivity among publicly funded clinic attendees in North Carolina. Abstract #267. 13th Meeting of the International Society for Sexually Transmitted Disease Research; Denver, CO; July 1999.
113. Fox KK, Haar M, Leone PA, Hoffman I, Owen-O'Dowd J, Privette A, Miller WC. Targeted screening for gonorrhea in North Carolina. Abstract #414. 13th Meeting of the International Society for Sexually Transmitted Disease Research; Denver, CO; July 1999.
114. Gibbs SH, Miller WC, Hoffman IF, Leone PA, Owen-O'Dowd J, McPherson JT, Schmitz JL. Clinical utility of white blood cells on vaginal wet mount and endocervical gram stain for the diagnosis of chlamydia and gonorrhea. Abstract #527. 13th Meeting of the International Society for Sexually Transmitted Disease Research; Denver, CO; July 1999.
115. Rogers E, Craft C, Miller W, Gilligan P. Comparison of time to detection of clinically significant bacteria isolated in standard aerobic versus resin bottles in the Bactec 9240 blood culture system. American Society of Microbiology; May 1999.
116. Bersoff-Matcha SJ, Miller WC, van der Horst C, Hamrick HJ Jr, Gase D, Powderly WG, Mundy LM. Gender differences in nevirapine rash. 6th Conference on Retroviruses and Opportunistic Infections; Chicago, IL; February 1999.
117. Pilcher CD, Miller WC, Beatty ZA, Nickischer D, Eron J. Detection of HIV RNA in plasma <400 copies/ml associated with virologic rebound. 6th Conference on Retroviruses and Opportunistic Infections; Chicago, IL; February 1999.
118. Morrison CS, Sekadde-Kigondu C, Miller WC, Weiner D, Sinei SK. Use of STD risk assessment algorithms for selection of IUD users. Session # 3067 (p 341), American Public Health Association Annual Meeting; Washington, DC; November 1998.
31 CURRICULUM VITAE - William C. Miller
119. Hoyo C, Miller WC, Newman B, Millikan R, Morris D, Suchindran C, Fortney J. Targeting high risk women for cervical neoplasia screening. An International Multidisciplinary Symposium on Cervical Cancer; Barcelona, Spain; March 1998.
120. Miller WC. Discrepant analysis: a biased evaluation of new diagnostic tests. Journal of General Internal Medicine. 1997;12 (Supplement 1): 55.
121. Miller WC, Hoffman IF, Leone PA, Owen-O’Dowd J, McPherson JT, Schmitz JL. A comparison of selective screening algorithms for chlamydial infection. Abstract # O108, International Congress of Sexually Transmitted Diseases; Seville, Spain; October 1997.
122. Miller WC. Screening for chlamydial infection: a probability of disease model. Abstract # O128, International Congress of Sexually Transmitted Diseases; Seville, Spain; October 1997.
123. Leone PA, Miller WC, Hoffman IF, Owen-O’Dowd J, Schmitz JL, McPherson JT, Hoyo C, Woodlief G. High prevalence of chlamydial infection in rural North Carolina. Abstract # P792, International Congress of Sexually Transmitted Diseases; Seville, Spain; October 1997.
124. Seña AC, Miller WC, Hoffman IF, Cohen MS, McKee KT. Gonorrhea among active duty personnel in a United States Army post. Abstract # P302, International Congress of Sexually Transmitted Diseases; Seville, Spain; October 1997.
125. Miller WC, Hoffman IF, Leone PA, Owen-O’Dowd J, McPherson JT, Schmitz JL. Assessment of selective screening algorithms for chlamydial infection. Abstract # 668, Infectious Diseases Society of America; San Francisco, CA; September 1997.
126. Schmitz JL, Woodlief GB, McPherson JT, Miller B, Hoffman I, Leone P. Comparison of DFA and LCR for verification of chlamydia EIA negative gray-zone results. American Society of Microbiology, Orlando, FL; May 1997.
127. Miller W. Discrepant analysis: a biased evaluation of diagnostic tests. Robert Wood Johnson Clinical Scholars Program National Meeting; Fort Lauderdale, FL; November 1996.
128. Miller W, Thielman N, Bearer E, Ting D, Swai N, Manyenga D, Mlalasi J, Lallinger G, Evaluation of five clinical case definitions of HIV/AIDS in African adults. Abstract #198, Infectious Diseases Society of America; New Orleans, LA; October 1993.
129. Miller W, Thielman N, Bearer E, Swai N, Manyenga D, Ting D, Mlalasi J, Lallinger G, Delayed- type hypersensitivity responses and HIV infection in hospitalized patients in Tanzania. Abstract #1401, Interscience Conf. on Antimicrobial Agents and Chemotherapy; New Orleans, LA; October 1993.
130. Lallinger G, Miller W, Durack D, Thielman N, Beiser C, Cegielski P, Shao J, Treatment of diarrhea with ciprofloxacin in HIV infected patients in Tanzania. Fifth International Congress for Infectious Diseases; Nairobi, Kenya; June 1992
131. Miller WC, DeLong MR, Altered neuronal activity in the globus pallidus in MPTP parkinsonism. Neural Mechanisms in Disorders of Movement Symposium; Manchester, United Kingdom; April 1988.
132. Miller WC, Mitchell SJ, Baker FH, DeLong MR, Neuronal activity in primate globus pallidus following MPTP treatment. Neural Control of Limb Movement Symposium; Seattle, WA; July 1986.
133. Miller W, DeLong M, Changes in neuronal activity in the monkey globus pallidus after MPTP treatment. International Basal Ganglia Society Symposium; Victoria, BC, Canada; July 1986.
32 CURRICULUM VITAE - William C. Miller
134. Miller WC, Mitchell SJ, Baker FH, DeLong MR, Instruction-dependent changes in neuronal activity in the primate globus pallidus. Soc. Neurosci. Abstr. Vol. 12, Part 1, p. 207, 1986.
Doctoral Dissertation
Examination of the motor abnormalities and changes in neuronal activity in the globus pallidus in the primate MPTP model of parkinsonism. 1988, 272 pages.
Master’s Paper
Discrepant analysis: A biased evaluation of new diagnostic tests. 1997, 35 pages.
Invited Seminars and Presentations
1. The Editorial and Review Process. The First South China-UNC Advanced STI Clinical and Research Training Course. Guangzhou, China; July, 2014.
2. Scientific Writing. The First South China-UNC Advanced STI Clinical and Research Training Course. Guangzhou, China; July, 2014.
3. Chlamydia. The First South China-UNC Advanced STI Clinical and Research Training Course. Guangzhou, China; July, 2014.
4. Challenges of Population Surveillance for STDs. 2014 STD Prevention Conference, Atlanta, GA; June, 2014.
5. STI’s in Space: Assessing the epidemiology of sexually transmitted infections using spatial information. Department of Infectious Diseases Epidemiology, Imperial College London, London, United Kingdom; February, 2014
6. North Carolina Cascade: What the numbers really mean. World AIDS Day 2013, University of North Carolina at Chapel Hill, Chapel Hill, NC; December 2013.
7. Geographical techniques to improve STI estimates. Consultation on methods for improved global STI estimates. World Health Organization, Geneva, Switzerland; November 2013.
8. Issues in Data Quality and Interpretation. Workshop to Strengthen Monitoring of HIV Care and Antiretroviral Therapy in the Western Pacific Region, World Health Organization Western Pacific Region Office, Vientiane, Laos; November 2012.
9. Metrics for Treatment as Prevention. Workshop to Strengthen Monitoring of HIV Care and Antiretroviral Therapy in the Western Pacific Region, World Health Organization Western Pacific Region Office, Vientiane, Laos; November 2012.
10. Current questions in chlamydia screening – panel discussion. Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia; November, 2012.
11. Is treatment enough prevention? Ontario HIV Treatment Network, Toronto, Ontario; November, 2012.
33 CURRICULUM VITAE - William C. Miller
12. Communicating research findings in a real-time world. Ontario HIV Treatment Network, Toronto, Ontario; November, 2012.
13. Community viral load. North Carolina Regional Quality Council; Raleigh, NC; June, 2012
14. Is community viral load a useful metric for treatment as prevention of HIV infection? RTI International, Research Triangle Park, NC; May, 2012
15. STI’s in Space: Assessing the epidemiology of sexually transmitted infections using spatial information. Program in Infectious Diseases Epidemiology, Department of Epidemiology, Harvard University School of Public Health, Boston, MA; April, 2012
16. Caution regarding the use of community viral load: conceptual issues. Metrics Workshop on Methods and Tools for Monitoring and Evaluating the Epidemiological Impact of Antiretroviral Treatment for Prevention. World Health Organization, Geneva, Switzerland; April 2012
17. Evidence that existing models have underestimated the role of early HIV infection on the HIV epidemic in Southern Africa. The Potential Impact of Expanded Access to Treatment for HIV Prevention in Sub-Saharan Africa - The HIV Modelling Consortium. Stellenbosch Institute for Advanced Studies, Stellenbosch, South Africa; November, 2011.
18. The future of HIV prevention in Africa: Is acute HIV infection important? Sponsored by The Ohio State University Health Sciences Center for Global Health and the Center for Microbial Interface Biology. Columbus, OH; November, 2010.
19. Leveraging Academic Partnerships to Maximize the Use of Surveillance Systems to Inform Disease Control Efforts. Region II Infertility Prevention Project Executive Committee Meeting, New York, NY; October, 2010.
20. The Natural Life Cycle of Scientists Working in the Clinical Translational Research Area and How One Builds a Sustainable Research Program. 2010 Clinical and Translational Research and Education Meeting. ACRT/SCTS Joint Annual Meeting, Washington, DC; April, 2010.
21. The Epidemiology of Chlamydial Infection: Are we losing ground? Plenary Session. 17th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Seattle, WA; July 2007.
22. Chlamydia and Other STIs in Young Adults in the U.S. - Lessons from the Adolescent Health Study Infertility Prevention Project, Region IV Advisory Board Meeting, Raleigh, NC. March 29, 2007.
23. Trich or Treat? Infectious Diseases Epidemiology Seminar. School of Veterinary Medicine, North Carolina State University. October 31, 2006.
24. Diagnosis: The Promise and the Pitfalls of Chlamydia Screening with Nucleic Acid Amplification Tests; Current Controversies in Chlamydia Screening: What Works and at what Cost. 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR), Amsterdam, The Netherlands; July 2005.
25. Interpretation of Diagnostic and Screening Tests, Global Health Outcomes Short Course in Epidemiology; Glaxo, Smith, Klein, Research Triangle Park, NC; November, 2004.
26. Diagnosis and Screening Methods, Center for Excellence in Pharmacoepidemiology and Public Health Methods Short Course, Research Triangle Park, NC; May, 2004.
34 CURRICULUM VITAE - William C. Miller
27. Update on Chlamydia: Testing and Treatment Guidelines, Eastern District North Carolina Public Health Association, New Bern, NC; May, 1998.
28. Screening for Chlamydial Infection: North Carolina’s Model, Region IV Chlamydia Project, Advisory Board Meeting, Charlotte, NC; October, 1997.
29. Chlamydia: Diagnosis and Treatment Issues, Women’s Health Symposium, Annual Update for Nurse Practitioners and Physician Assistants in Family Planning and Prenatal Clinics, Greensboro, NC; May, 1997.
30. Chlamydia: Diagnosis and Treatment in the 1990s, Videoconference, HIV/STD Control Section, Division of Epidemiology, Dept. of Environment, Health and Natural Resources, Raleigh, NC; May, 1997.
31. Sexually Transmitted Diseases Seminar, Division of HIV/STD Prevention, North Carolina Department of Environment, Health and Natural Resources, Raleigh, NC; March, 1997.
32. Infectious Diseases Seminar, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; February, 1997.
33. International Health Care: Issues and Opportunities, American Medical Association - Medical Student Section, Southeast Regional Conference, Chapel Hill, NC; February, 1997.
34. Clinical Manifestations of Malaria, Morbidity and Mortality Conference, Dept. of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; June, 1996.
35. Volunteering in the Developing World, Dept. of Emergency Medicine and Office of Continuing Medical Education, Duke University Medical Center, Durham, NC; March, 1996.
36. Volunteering in the Developing World, Dept. of Emergency Medicine and Office of Continuing Medical Education, Duke University Medical Center, Durham, NC; April, 1995.
37. AIDS Symposium, Dept. of Biology, Campbell University, Buies Creek, NC; April, 1994.
38. AIDS Symposium, Dept. of Biology, Campbell University, Buies Creek, NC; March, 1993.
39. Grand Rounds, Caldwell Memorial Hospital, Lenoir, NC; November, 1992.
40. Dept. of Biology, Neuroscience Journal Club, University of Maryland, Baltimore County; April, 1987.
41. National Institute of Neurological and Communicative Disorders and Stroke, Experimental Therapeutics Branch; December, 1986.
Teaching Experience
Course Director or Co-Director - UNC
2013 - present Course Director, Clinical Research Skills II (EPID 803) MSCR Program (Translational and Clinical Research Curriculum, TraCS Institute), Department of Epidemiology, Gillings School of Global Public Health, UNC at Chapel Hill
2012 - present Course Director, Clinical Research Skills I (EPID 802; EPID 690, section 003) MSCR Program (Translational and Clinical Research Curriculum, TraCS
35 CURRICULUM VITAE - William C. Miller
Institute), Department of Epidemiology, Gillings School of Global Public Health, UNC at Chapel Hill
2006 - present Course Co-Director, Clinical Research Methods (EPID 805/806; previously EPID 205/206) MSCR Program (Translational and Clinical Research Curriculum, TraCS Institute), Department of Epidemiology, Gillings School of Global Public Health, UNC at Chapel Hill
2001 - present Course Co-Director, Clinical Research and Professional Development Seminar, (EPID 896, previously EPID 305) MSCR Program (Translational and Clinical Research Curriculum, TraCS Institute), Department of Epidemiology, Gillings School of Global Public Health, UNC at Chapel Hill
1997 - present Course Director, Clinical Measurement and Evaluation (PUBH 260/EPID 170; EPID 711/PUBH 760), Public Health Leadership Program and Department of Epidemiology, Gillings School of Global Public Health, UNC at Chapel Hill
2009 Course Director, Design of Clinical Research Studies (EPID 690), Department of Epidemiology, Gillings School of Global Public Health, UNC at Chapel Hill
1997 - 2009 Course Director, Clinical Epidemiology, General Medicine Faculty Fellows Program, School of Medicine, UNC at Chapel Hill
2006 Course Director, Epidemiology of Sexually Transmitted Infections, Department of Epidemiology, School of Public Health, UNC at Chapel Hill
2000 - 2002 Co-Instructor, (Co-Director) Theory and Quantitative Methods in Epidemiology (EPID 268), Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill
1999 Course Director, Methods in Clinical Epidemiology: Application and Interpretation, (EPID 141), Department of Epidemiology, UNC at Chapel Hill
1998 - 1999 Co-Instructor, Control of Infectious Diseases in Developing Countries (EPID 226), Department of Epidemiology, School of Public Health, UNC at Chapel Hill
1997 - 1999 Co-Director, Introduction to Methods of Infectious Diseases Epidemiology (EPID 218), Department of Epidemiology, UNC at Chapel Hill
1996 Teaching Assistant/Co-Instructor, Clinical Epidemiology (EPID 140), Department of Epidemiology, School of Public Health, UNC at Chapel Hill
Course Director or Co-Director – Outside of UNC
2014 Instructor, Scientific Writing, Internationaler Kurs der Epidemiologie, Summer Course(s), five 3 hour sessions, Universität Ulm, Ulm, Germany
2000 - 2002, Instructor, Clinical Epidemiology, Internationaler Kurs der Epidemiologie, 2007, 2009, 2013 Summer Course(s), five 3 hour sessions, Universität Ulm, Ulm, Germany
2005 - 2009 Course Director, Advanced Epidemiology, MPH Program, College of Medicine, Blantyre, Malawi
36 CURRICULUM VITAE - William C. Miller
2007 Course Co-Director, Clinical Trials, College of Medicine, Blantyre, Malawi
2006 Course Director, Clinical Epidemiology, Advanced Epidemiology Summer Institute, Heidelberg, Germany
Lectures in UNC Courses
2002 - present BIOS 542/PUBH 742, Quantitative Methods for Health Care Professionals, Predictive Models & Risk Score Development, 2 hours/year, Department of Epidemiology, School of Public Health, UNC at Chapel Hill
2011 - present MHCH 740, Global Sexual and Reproductive Health, Guest lecture - STIs, 1.5 hours/year, Dept. of Maternal and Child Health, Gillings School of Global Public Health, UNC at Chapel Hill
2009, 2011 MHCH 701, Foundations in MCH, Guest lecture - HIV infection, 1.5 hours/year, 2012, online Dept. of Maternal and Child Health, School of Public Health, UNC at Chapel Hill
1999 - 2010 EPID 718 (EPID 269), Advanced Methods for Epidemiologic Data Analysis, 1 – 2 hours/year, Department of Epidemiology, School of Public Health, UNC at Chapel Hill
1998 - 2000, PUBH 750, Strategies of Prevention for Clinicians, 2 hours/year, Public Health 2002, 2004-10 Leadership Program, School of Public Health, UNC at Chapel Hill
1996 - 2006 Core Curriculum (Epidemiology 205 – 206), Basic Epidemiology and Study Design, (multiple guest lectures), Robert Wood Johnson Clinical Scholars Program, UNC at Chapel Hill
1998 - 1999, MCH 210, Maternal and Infant Health and Family Planning, 1.5 – 2 hours/year, 2001 - 2005 Dept. of Maternal and Child Health, School of Public Health, UNC at Chapel Hill
1998 - 2001 EPID 390, Doctoral Seminar: History and Philosophy of Epidemiology, 2 hours/year, Dept. of Epidemiology, School of Public Health, UNC at Chapel Hill
1998 - 1999 EPID 268, Theory and Quantitative Methods in Epidemiology, 2 hours/year Department of Epidemiology, School of Public Health, UNC at Chapel Hill
1999 EPID 224, Methods in the Study and Control of Sexually Transmitted Diseases, 2 hours, Dept. of Epidemiology, School of Public Health, UNC at Chapel Hill
1999 EPID 201, Epidemiologic Research Methods, 1.25 hours, Department of Epidemiology, School of Public Health, UNC at Chapel Hill
Lectures in UNC Seminars
2000, 2002 - 2003 Medical Scholars Program, 1.5 hours/year, School of Medicine, 2005 - 2008 UNC at Chapel Hill
1997 - 1998, Measurement in Clinical Research, Clinical Research Summer Course, 2000 - 2003 1 hour/year, School of Medicine, UNC at Chapel Hill
37 CURRICULUM VITAE - William C. Miller
1998 - 2002 Career Development, UNC RWJ Clinical Scholars Program, 1 hour/year
2000 Study Design, Measures of Frequency & Association, Multivariate Analysis; Medical Residents’ Curriculum, 3 hours, Dept. of Medicine, UNC at Chapel Hill
1999 Medicine and Society, 2 hours, School of Medicine, UNC at Chapel Hill
1999 Ethics, Infectious Diseases Epidemiology, 2 hour, Department of Epidemiology, School of Public Health, UNC at Chapel Hill
1998 Diagnostic Test Evaluation, Primary Care Fellowship, 1 hour, School of Medicine, UNC at Chapel Hill
1998 CPC, 1 hour, Department of Medicine, School of Medicine, UNC at Chapel Hill
Grand Rounds at UNC
2002 Evaluating Diagnostic Tests: Study Designs, Bias, and Presentation of Results. Department of Pathology, UNC School of Medicine.
1999 Race/Ethnicity in Medical Research, Department of Medicine, UNC School of Medicine.
Continuing Education
2005 Sexually Transmitted Diseases Update, AHEC Lecture
2003 Infectious Diseases Update, AHEC Lecture, Nash General Hospital
Other Teaching Activities
1993 - 1994 Bacterial Infections Curriculum (two hour lecture in each year), Physician’s Assistant Program, Duke University, Durham, NC
1991 Infectious Diseases Curriculum (four lectures), Internal Medicine Residency Program, Muhimbili Medical Centre, Dar es Salaam, Tanzania
1986 Teaching Assistant, Neuroscience Laboratory, Johns Hopkins University School of Medicine
Attending on Clinical Service
1997 - present Infectious Diseases Consult Service, ∼ 1-2 months per year, Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill
38 CURRICULUM VITAE - William C. Miller
1997 - 2010 Moore Regional Hospital Infectious Diseases Consult Service, ∼ 0.5 – 1 month per year, Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill
1997 - 2001 Inpatient Ward Service, ∼0.5 – 1 month per year, Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill
Graduate Student Advising and Committees at UNC
1997 - present 30 Students (completed), Ph.D. Committee Chairperson or Advisor, Dept. of Epidemiology
1997 - present 29 Students (completed), Ph.D Doctoral Committee Member, Dept. of Epidemiology
1997 - present 7 Students (completed), Ph.D. Doctoral Committee Member, Depts. of Biostatistics, Nutrition, Health Policy and Administration and Health Behavior and Education, Maternal and Child Health
1997 - present 38 Students (completed), M.P.H. Master's Paper Advisor, Dept. of Epidemiology
1997 - present 6 Students (completed), M.S.P.H. Master's Paper Advisor, Dept. of Epidemiology
1997 - present 25 Students (completed), M.P.H. Master's Paper Advisor, Health Care and Prevention Program
1997 - present 7 Students (completed), M.P.H. Master's Paper Reader, Dept. of Epidemiology
1997 - present 1 Students (completed), M.S.P.H. Master's Paper Reader, Dept. of Epidemiology
1997 - present 4 Students (completed), M.P.H. Master's Paper Reader, Health Care and Prevention Program
1999 2 Students (completed), M.P.H. Master's Paper Advisor, Dept. of Maternal and Child Health; Executive Master's Program, Dept. of Health Policy and Administration
Graduate Student Advising and Committees – Outside of UNC
1999 Frieda Behets, Ph.D. External Reader, Yale University
Graduate Student (Doctoral Committee Chair/Advisor) and Post-doctoral Prizes Given to Trainees
2012 Brooke Hoots, 2012 GEAB Impact Award Winners for Research Benefitting the State of North Carolina, University of North Carolina at Chapel Hill, Chapel Hill, NC
2011 Kimberly Powers, Postdoctoral Award for Research Excellence, University of North Carolina at Chapel Hill, Chapel Hill, NC
39 CURRICULUM VITAE - William C. Miller
2008 Kimberly Powers, Kaplan Student Publication Award, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
2008 Sandi McCoy, Graduate Education Advancement Board Recognition Award for Dissertation Research of Benefit to North Carolina, University of North Carolina at Chapel Hill
2008 Lynne Sampson, Graduate Education Advancement Board Recognition Award for Dissertation Research of Benefit to North Carolina, University of North Carolina at Chapel Hill
2007 Cheryl Stein, Student Prize Paper, American College of Epidemiology
2006 Brian Wells Pence, Graduate Education Advancement Board Recognition Award for Dissertation Research of Benefit to North Carolina, University of North Carolina at Chapel Hill
2003 Dionne Gesink Law, Dean's Award for Graduate and Professional Students, University of North Carolina at Chapel Hill
Graduate Student Independent Funding Mentor/Sponsor
2012 - 2017 Sarah Rutstein, F30 (MD-PhD traineeship), National Institute of Mental Health
2011 - 2015 Rushina Cholera, F30 (MD-PhD traineeship), National Institute of Mental Health
2008 - 2012 Lillian Brown, F30 (MD-PhD traineeship), National Institute of Mental Health
Post-doctoral Fellows, non-degree, Mentor/Sponsor
2012 - present Veronica Escamilla (primary mentor; Michael Emch, co-mentor)
2011 - 2013 Kimberly Powers (primary mentor; Myron Cohen, co-mentor)
2011 - 2013 Claire Farel, (co-mentor; David Wohl, primary mentor)
Junior Faculty, Mentor/Co-mentor
2014 - present Eveline Wu, Department of Pediatrics (mentor)
2013 – present Jennifer H. Tang, Department of Obstetrics & Gynecology (co-mentor); K01 (Fogarty)
2013 - present Brian Wells Pence, Department of Epidemiology (mentor)
2013 - present Kimberly Powers, Department of Epidemiology (mentor); KL2 mentor
2013 - present Christopher Hurt, Division of Infectious Diseases, Department of Medicine; K-23 NIAID
40 CURRICULUM VITAE - William C. Miller
2012 - present Satish Gopal, Divisions of Infectious Diseases & Hematology/Oncology, Department of Medicine; K-01 (Fogarty)
2011 - present Ann Dennis, Division of Infectious Diseases, Department of Medicine; KL2 scholar; K08 (co-mentor)
2010 - present Laura Loehr, Department of Epidemiology (co-mentor)
2012 - 2014 Jon Samuel, Department of Surgery; K-01 (Fogarty)
2008 - 2012 Audrey Pettifor, Department of Epidemiology (co-mentor)
2008 - 2012 Pia MacDonald, Department of Epidemiology (co-mentor)
Teaching-related Administrative Activities
2009 - present Director, Masters of Science in Clinical Research (MSCR) Program, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
2008 - present Curriculum Director; Education, Training, and Career Development Core, NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill
1997 - 2011 Core Faculty, Health Care and Prevention Program, Public Health Leadership Program, School of Public Health, University of North Carolina at Chapel Hill
1997 - 1998, Core Faculty, General Medicine Faculty Development Program, School of 1999 - 2009 Medicine, University of North Carolina at Chapel Hill
2007 - 2008 Core Faculty; Executive Committee, Roadmap K12 Program, School of Medicine, University of North Carolina at Chapel Hill
1999 - 2008 Core Faculty, Clinical Research Curriculum (K30 Award), School of Medicine, University of North Carolina at Chapel Hill
1999 - 2005 Core Faculty, Robert Wood Johnson Clinical Scholars, School of Medicine, University of North Carolina at Chapel Hill
Grants and Independent Support
Ongoing
Principal Investigator and Protocol Chair
2010 - 2015 Project Director, Training in Sexually Transmitted Diseases and HIV (T32); Total direct costs $2,224,739; National Institute of Allergy and Infectious Diseases (T32 AI007001)
2013 - 2017 Protocol Chair, HPTN 074, Integrated treatment and prevention for people who inject drugs: A vanguard study for a network-based randomized HIV prevention trial comparing an integrated intervention including supported antiretroviral therapy to the standard of care (HIV Prevention Trials Network; National Institute
41 CURRICULUM VITAE - William C. Miller
of Allergy and Infectious Diseases, National Institute of Drug Abuse; P.O. #8011- 39050 (Cohen))
2014 - 2018 Principal Investigator, Reaching Unaware Sexual and Social Contacts to Interrupt Ongoing HIV Transmission. Total direct costs $1,999,979; National Institute of Allergy and Infectious Diseases (R01AI114320)
Co-Investigator
2014 - 2019 Co-Investigator; Mina Hosseinipour, PI. Option B+: ART safety and durability during first and subsequent pregnancies. Total direct costs $3,278,056; 5% FTE, National Institute of Child Health and Human Development (R01HD080485)
2014 - 2018 Co-Investigator; Samantha Meltzer-Brody, PI. Epidemiological and genetic predictors of postpartum mood disorders. Total direct costs $2,296,500; 15% FTE, National Institute of Mental Health (R01 MH104468)
2013 - 2015 Co-Investigator; Kimberly Powers, PI. Evaluating Community Viral Load and other Metrics for HIV Treatment as Prevention. Annual direct costs $50,000; 5% FTE, National Institute of Mental Health (R03 MH100987)
2013 - 2014 Co-Investigator; Kimberly Powers, PI (Ron Swanstrom, CFAR PI). The HIV Treatment Cascade: Improving Measurement to Target Interventions (UNC CFAR supplement). Annual direct costs $100,000; 5% FTE, National Institute of Allergy and Infectious Diseases (P30 AI030410, supplement)
2012 - 2016 Co-Investigator; Donald Rubinow & Patrick Sullivan, PIs. Identifying Biomarkers for Post-Partum Depression in African-American Women. Annual total costs $888,156; 4% FTE, National Institute of Mental Health (R01 MH095992)
2006 - 2015 Co-Investigator; Myron S. Cohen, P.I., HIV in Semen-Effects of STDs and Antiviral Therapy. Annual direct costs $240,203; 10% FTE; National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK049381)
Completed
Principal Investigator
2009 - 2014 Principal Investigator, Acute HIV Infection: A key link for transmission prevention; Total direct costs $2,426,151; 20% FTE; National Institute of Allergy and Infectious Diseases (R01 AI083059)
2006 - 2012 Principal Investigator, Spatial epidemiology of syphilis and gonorrhea in North Carolina; Total direct costs $1,261,202; 25% FTE; National Institute of Allergy and Infectious Diseases (R01 AI067913)
2004 - 2009 Project Director, Prevention of Mother to Child Transmission Program – Russia; Total direct costs $1,450,309; 20-25% FTE; Elizabeth Glaser Pediatric AIDS Foundation
1999 - 2004 Principal Investigator, Health Care and Epidemiology of Sexually Transmitted Diseases Among Young Adults, Project 5 of the University of North Carolina Sexually Transmitted Diseases Clinical Research Center (Fred Sparling, P.I.),
42 CURRICULUM VITAE - William C. Miller
Project 5 five year total direct costs: $654,121; 25% FTE; National Institute of Allergy and Infectious Diseases (U01 AI31496)
2000 - 2002 CAP Award, 2 year salary support extension, effective 7/1/00 - 6/30/02, National Center for Research Resources, National Institutes of Health (M01 RR00046)
1998 - 2002 Co-Principal Investigator, (Peter Leone, Co-PI); HIV Prevention through Coordinated STD Services in a Southern Community, Direct Costs $286,000/year; 20% FTE; Centers for Disease Control and Prevention (UR1/CCU415542)
1997 - 2000 CAP Award, 3 year salary support effective 7/1/97 - 6/30/00, National Center for Research Resources, National Institutes of Health (M01 RR00046)
1993 - 1994 Fellowship in Medical Mycology, National Foundation for Infectious Diseases
1986 - 1988 National Research Service Award, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD
1982 Summer Research Fellowship, National Institute of Mental Health, Bethesda, MD
Co-investigator
2012 - 2014 Co-Investigator; Cynthia Gay, P.I., Screening targeted populations to interrupt ongoing chains of transmission with enhanced partner notification. Annual direct costs $505,293; 10% FTE; Centers for Disease Control and Prevention (U01 PS001559)
2009 - 2014 Co-Investigator; Terrie Taylor and Don Mathanga, P.I., Michigan State University and Malawi College of Medicine. From training & research to best practice: The Malaria Partnership for Excellence. Annual direct costs $18,719 (to UNC); 5% FTE; Fogarty Center, NIH (D43 TW008267)
2008 - 2011 Co-Investigator; Irving Hoffman, P.I. , PATH Malaria Initiative. Direct costs $262,947; 5% FTE; Program of Appropriate Technology in Health
2008 - 2010 Co-Investigator; Michael Murray, P.I., Addressing knowledge gaps in the treatment of depression. Direct costs $187,978; 5% FTE; Agency for Healthcare Research and Quality (HHSA290200500401)
2005 - 2010 Co-Investigator; Elizabeth Eggleston, P.I., Research Triangle Institute; Monitoring STIs in the Population. Total direct costs $202,806 (to UNC); 10% FTE; National Institute of Child Health and Development (R01 HD047163)
2004 - 2009 Co-Investigator; P. Fred Sparling, P.I. North Carolina STI/TM Cooperative Research Center, Project 1 – STD and HIV Co-Transmission (Cohen, P.I.); Project 1 direct costs $165,220; 5% FTE; National Institute of Allergy and Infectious Diseases (U01 AI131496)
43 CURRICULUM VITAE - William C. Miller
2003 - 2008 Co-Investigator; Christopher Pilcher, P.I. Targeting Acute HIV Infection, Total direct costs $1,125,000; 10% FTE; National Institute of Mental Health (R01 MH068686)
2003 - 2006 Co-Investigator, Irving F. Hoffman, P.I. Sexual and Reproductive Health Program, Bangladesh; Direct costs $290,759; 5% FTE; Family Health International
2001 - 2006 Co-Investigator; Susan M. Rogers, P.I., Research Triangle Institute; Transmissibility of GC and Ct diagnosed using NAAT. Total direct costs $3,401,270; 20% FTE; National Institute of Child Health and Development (R01 AI39633)
2000 - 2006 Co-Investigator; Irving F. Hoffman, P.I. HIV Prevention Trials Network, Russia; Direct costs $1,324,063; 5% FTE; National Institute of Allergy and Infectious Diseases (U01 AI47987)
1997 - 2003 Co-Investigator; Myron S. Cohen, P.I. Sexually Transmitted Diseases Clinical Trials Unit – Microbicide; Direct Costs $676,642; 5% FTE; National Institute of Allergy and Infectious Diseases (N01 AI75329)
Professional Service Activities
Scientific Consulting Activities – Outside of UNC, including Workshops and Panels
2013 Consultant. Consultation on methods for improved global STI estimates. World Health Organization, Geneva, Switzerland; November 2013.
2013 Participant, Finding Persons Unaware of their HIV-1 Infection, National Institutes of Health, Bethesda, MD; April 2013
2012 Temporary Advisor, Workshop to Strengthen Monitoring of HIV Care and Antiretroviral Therapy in the Western Pacific Region, Vientiane, Laos; November 2012
2012 Consultant, Metrics Workshop on Methods and Tools for Monitoring and Evaluating the Epidemiological Impact of Antiretroviral Treatment for Prevention. World Health Organization, Geneva, Switzerland; April 2012
2012 2012 Division of Sexually Transmitted Diseases Research Agenda Meeting, Centers for Disease Control and Prevention, Atlanta, GA; February 2012
2011 Advisor, Screening coverage for Chlamydial Infection, Centers for Disease Control and Prevention, July, 2011.
2008 External Advisor, PROCESS – Prospective Contraceptive Effectiveness and Safety Study, Advisor to Centers for Disease Control and Prevention Investigators, November, 2008
2008 Consultant, Infertility Prevention Project, National STD Prevention Conference
2006 Consultant, Screening for Chlamydia in Men, Centers for Disease Control and Prevention
44 CURRICULUM VITAE - William C. Miller
2002 Consultant, Centers for Disease Control and Prevention (see Centers for Disease Control and Prevention. Screening Tests to Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections – 2002. MMWR 2002;51 (no.RR-15).)
1999 Participant, Statistical and Quantitative Methods Used in Screening and Diagnostic Tests, Centers for Disease Control and Prevention
Committee Memberships - Outside of UNC
2012 - 2014 Data Safety Monitoring Board (Chair), Women’s Health CoOp Plus, Research Triangle Institute
2011 Data Safety Monitoring Board (Chair), Shang Ring Circumcision RCT, Family Health International
2001 Data Safety Monitoring Board, Project Shield, Research Triangle Institute
2001 Data Safety Monitoring Board, Randomized Clinical Trial of Vasectomy Procedures, Family Health International
1998 - 2001 Steering Committee, North Carolina Coalition for the Prevention of STDs
1995 - 1997 International Health Advisory Committee, Division of International Health, Duke University Medical Center, Durham, NC
Editorial Positions
2015 - present Editor, Sexually Transmitted Diseases
2011 - 2014 Associate Editor, Sexually Transmitted Infections
2010 - present Special Editor for Infectious Diseases, Epidemiology
2003 - 2014 Editorial Board, Sexually Transmitted Diseases
Committee Memberships within UNC
1997 - 1999, Admissions Committee, Department of Epidemiology, School of Public Health, 2000 - 2002, University of North Carolina at Chapel Hill 2006 - present
2011 University Teaching Awards Committee, University of North Carolina at Chapel Hill
2011 Administrative Review Committee for Dean Bill Roper of the UNC School of Medicine as well as CEO of the UNC Health Care System, School of Medicine, University of North Carolina at Chapel Hill
2003, 2006 Developmental Core Project Review, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill
45 CURRICULUM VITAE - William C. Miller
1999 - 2000, Graduate Studies Committee, Department of Epidemiology, School of Public 2002 - 2006 Health, University of North Carolina at Chapel Hill
2000, 2002 - 2006 Curriculum Subcommittee, Graduate Studies Committee, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill
2002 Study Section, UNC Medical Student Research, School of Medicine, University of North Carolina at Chapel Hill
1998 - 2002 Clinical Research Advisory Committee, General Clinical Research Center, School of Medicine, University of North Carolina at Chapel Hill
1998 Instruction of Epidemiological Methods Review Committee, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill
Ad Hoc Journal Reviews
JAMA, Annals of Internal Medicine, Lancet, American Journal of Public Health, PLoS One, Epidemiology, American Journal of Epidemiology, International Journal of Epidemiology, Annals of Epidemiology, Epidemiology & Infection, Journal of Clinical Epidemiology, Journal of Infectious Diseases, Clinical Infectious Diseases, Lancet Infectious Diseases, AIDS, Journal of AIDS, Sexually Transmitted Diseases, Sexually Transmitted Infections, Journal of Adolescent Health, Human Reproduction, Preventive Medicine, Johns Hopkins Advanced Studies in Medicine, American Journal of Managed Care, Public Health Nutrition, Journal of the American Women's Medical Association, Southern Medical Journal, BME Infectious Diseases, Journal of Virology, AIDS & Behavior, Medical Decision-Making
Abstract Reviews for Conferences
2011 2012 CDC National STD Prevention Conference
2011 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011), Rome, Italy
2010 AIDS 2010 Conference, Vienna, Austria
2009 18th ISSTDR, 2009, London, U.K.
2007 17th ISSTDR, 2007, Seattle, WA
Grant Reviews
2014 ZRG1 AARR-C 22 L, Fellowships: AIDS and AIDS-Related Applications, November 2014
2011 ZMH1 ERB-D (01) S, NIMH, HIV: Treatment Engagement and Retention, November, 2011
46 CURRICULUM VITAE - William C. Miller
2010 ZRG1 HDM-K 55 R, OD-10-005 Director's Opportunity 5 Themes Healthcare Deliveries and Methodologies, May, 2010
2009 Special Emphasis Panel ZRG1 HDM-G 02 M, Health Services Research Member Application, Healthcare Delivery and Methodologies IRG, October, 2009
2006 Centers for Disease Control and Prevention, Special Emphasis Panel Review Meeting (Study Section), May, 2006
2005 Medical Research Council, Sexual Health and HIV Research Strategy Committee, United Kingdom
2003 The Wellcome Trust, Wellcome Research Leave Award
2001 Centers for Disease Control and Prevention: Special Emphasis Panel, HIV Prevention Intervention Research Studies Routinely Recommending HIV and STD Counseling and Testing in Ambulatory Care Clinics and Emergency Rooms
2000 National Cancer Institute: Subcommittee E
47